AaronHeng personal page - To The Moon

AaronHeng

AaronHeng

No personal profile

8Follow

0Followers

0Topic

0Badge

2021-07-06

$Zomedica Pharmaceuticals Corp.(ZOM)$Truforma is going to change the pet industry

2023-01-26

$BOIL 20230203 11.0 CALL$ $BOIL 20230203 11.0 CALL$

2021-07-26

$Sundial Growers Inc.(SNDL)$hodling till 1.5 price target

2021-05-28

Please like and comment

Sorry, the original content has been removed

2021-06-14

Like and comment

A Meme Stock Is Born: How to Spot the Next Reddit Favorite

2021-06-24

Breaking news indeed

The ‘incredible’ U.S. tech stocks to buy when there’s a dip: Investor

2021-08-25

Just bought 10k worth of $zom shares

Sorry, the original content has been removed

2021-06-18

Have not read but please like and comment

Alibaba Stock: The Bottoming Process Looks To Be Forming Already

2021-07-28

$Sundial Growers Inc.(SNDL)$im super bullish on this , going to 5 dollars EOY

2021-07-09

$Zomedica Pharmaceuticals Corp.(ZOM)$HHappy

2021-07-05

$Zomedica Pharmaceuticals Corp.(ZOM)$will average down

2021-07-02

Like and comment to see Tesla to 723 by end of July

Tesla top-of-range car caught fire while owner was driving, lawyer says

2021-06-16

Interest read, please like and share

It’s time to be smart like Soros in the ‘blow-off’ stage of the bull market in stocks

2022-02-14

$CTI BioPharma(CTIC)$Fda soon diamond hands

2021-07-12

$Workhorse(WKHS)$it should hover around 12-13 dollars by end of this week

2021-06-15

Nicely done

IPO Preview: WalkMe, Atai Life Sciences Highlight Week Of Many Offerings

2021-05-19

You are not alone

@IreneCQ:$ArcLight Clean Transition Corp(ACTC)$Nooo

2021-09-11

Nice to spread fud , I don't think value investment is the in thing now , memestock ftw

5 Ultra-Popular Stocks to Avoid Like the Plague in September

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":3582700103615177,"uuid":"3582700103615177","gmtCreate":1619611566570,"gmtModify":1620023045997,"name":"AaronHeng","pinyin":"aaronheng","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":8,"tweetSize":40,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.24","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.05.07","exceedPercentage":"80.01%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.30","exceedPercentage":"93.78%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":1,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":9952696483,"gmtCreate":1674665763142,"gmtModify":1676538951858,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://ttm.financial/OPT/BOIL 20230203 11.0 CALL\">$BOIL 20230203 11.0 CALL$ </a><a href=\"https://ttm.financial/OPT/BOIL 20230203 11.0 CALL\">$BOIL 20230203 11.0 CALL$&nbsp;</a> &nbsp;","listText":"<a href=\"https://ttm.financial/OPT/BOIL 20230203 11.0 CALL\">$BOIL 20230203 11.0 CALL$ </a><a href=\"https://ttm.financial/OPT/BOIL 20230203 11.0 CALL\">$BOIL 20230203 11.0 CALL$&nbsp;</a> &nbsp;","text":"$BOIL 20230203 11.0 CALL$ $BOIL 20230203 11.0 CALL$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9952696483","isVote":1,"tweetType":1,"viewCount":257,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9095115453,"gmtCreate":1644850664500,"gmtModify":1676533967854,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/CTIC\">$CTI BioPharma(CTIC)$</a>Fda soon diamond hands","listText":"<a href=\"https://ttm.financial/S/CTIC\">$CTI BioPharma(CTIC)$</a>Fda soon diamond hands","text":"$CTI BioPharma(CTIC)$Fda soon diamond hands","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095115453","isVote":1,"tweetType":1,"viewCount":355,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":881388490,"gmtCreate":1631293095210,"gmtModify":1676530523202,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"Nice to spread fud , I don't think value investment is the in thing now , memestock ftw","listText":"Nice to spread fud , I don't think value investment is the in thing now , memestock ftw","text":"Nice to spread fud , I don't think value investment is the in thing now , memestock ftw","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/881388490","repostId":"2165353911","repostType":2,"repost":{"id":"2165353911","pubTimestamp":1631015340,"share":"https://www.laohu8.com/m/news/2165353911?lang=&edition=full","pubTime":"2021-09-07 19:49","market":"us","language":"en","title":"5 Ultra-Popular Stocks to Avoid Like the Plague in September","url":"https://stock-news.laohu8.com/highlight/detail?id=2165353911","media":"Motley Fool","summary":"Popularity doesn't necessarily translate to profitability on Wall Street.","content":"<blockquote>\n <b>Popularity doesn't necessarily translate to profitability on Wall Street.</b>\n</blockquote>\n<p><b>Key Points</b></p>\n<ul>\n <li>Though the S&amp;P 500 is soaring, the valuations of these stocks make little sense.</li>\n</ul>\n<p>For more than 17 months, investors have enjoyed a historic bounce-back rally in the stock market. Following the quickest decline of at least 30% in the history of the broad-based <b>S&amp;P 500</b>, the index has since rallied more than 100% off of its low.</p>\n<p>But just because the market is in rally mode, it doesn't mean every stock deserves its current valuation. The following five ultra-popular stocks are on the radar for all the wrong reasons, and they should be avoided like the plague in September.</p>\n<p><img src=\"https://static.tigerbbs.com/8b2e6f5c48ac79126a7c69a95b9659ed\" tg-width=\"700\" tg-height=\"484\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<p><b>AMC Entertainment</b></p>\n<p>As I stated last month, movie theater chain <b>AMC Entertainment </b>(NYSE:AMC) will be the top stock to avoid until its share price accurately reflects the ghastly performance of its underlying business and its ugly balance sheet.</p>\n<p>There pretty much isn't a fundamental factor working in AMC's favor at the moment. Box office ticket sales have consistently been 30% or more below what they were in 2019, and ticket sales had been declining at a fairly steady clip since 2002. CEO Adam Aron has touted AMC's ability to pick up market share during the pandemic, but he overlooks that the actual movie theater pie has been shrinking for two decades.</p>\n<p>More specific to the company, it burned through close to $577 million in cash in just the first six months of 2021. It's also sitting on $5.5 billion in corporate debt, along with $420 million in deferred rent, all of which will need to be repaid in cash. AMC's cash balance at the end of June was a hair over $1.8 billion, or roughly $2 billion if you include the company's untapped revolving credit line. No matter how you finagle the numbers, AMC has virtually no chance of repaying its obligations, and its bondholders know it, which is why more than $1 billion in combined 2026/2027 maturity bonds are valued at 60% to 65% of face value.</p>\n<p>The icing on the cake here is that a multitude of theses surrounding an AMC short squeeze aren't supported by fact. Put plainly, a company that was never worth more than $3.8 billion when it was profitable and could pay its debt obligations shouldn't be worth $22 billion when it's hemorrhaging cash and can't pay its obligations.</p>\n<p><img src=\"https://static.tigerbbs.com/0c88358ead583aa5db4844d5902510f8\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<p><b>Zomedica</b></p>\n<p>Generally speaking, penny stocks (companies with a share price below $5) are penny stocks for a reason. In other words, companies sport a low share price because they're not performing well from an operating standpoint. That's the case with veterinary medicine and diagnostics company <b>Zomedica </b>(NYSEMKT:ZOM).</p>\n<p>On the surface, there's a lot to like. Pet expenditures in the U.S. haven't declined on a year-over-year basis in more than a quarter of a century, and an estimated $32.3 billion will be spent this year in the U.S. on veterinary care and product sales, according to the American Pet Products Association.&nbsp; To boot, Zomedica launched its first-ever commercial product in March. Truforma, as it's known, is a point-of-care diagnostics system for cats and dogs.</p>\n<p>The problem is that Truforma just isn't selling. While the company blamed its commercial launch challenges on the sale of its distribution partner, it's still an eye-opener that the company has managed only $29,817 in total sales since its March launch. Although sales will undoubtedly grow as management works out the kinks, I have to wonder what investor wants to pay a multiple of almost 40 times estimated sales for 2022.</p>\n<p>With no clear pathway to profitability anytime soon, and management diluting the daylights out of its shareholders to raise cash (there are nearly 980 million outstanding shares), Zomedica is an easy avoid in September.</p>\n<p><img src=\"https://static.tigerbbs.com/ebe3f403b1b970d0e231952ef9c1d01c\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<p><b>Robinhood Markets</b></p>\n<p>Another ultra-popular stock that should be draped in yellow caution tape for September is online investing app <b>Robinhood Markets</b> (NASDAQ:HOOD).</p>\n<p>On <a href=\"https://laohu8.com/S/AONE.U\">one</a> hand, Robinhood has seen its user growth blossom since the pandemic began. In the 18-month period between Dec. 31, 2019 and June 30, 2021, the company's funded accounts have grown from about 10 million to 22.5 million. It also now has more than $100 billion in assets under custody. As retail investors have flocked to Robinhood, revenue has soared.</p>\n<p>But this doesn't tell the full story. Even though its customer count has risen, Robinhood has rubbed retail investors and U.S. regulators the wrong way. The company had to pare back trading activity earlier this year on heavily shorted meme stocks (companies lauded for their social media buzz, rather than their operating performance) because it lacked the capital to support heightened trading activity. It's drawn ire from regulators over its sale of order flow to hedge funds, as well.</p>\n<p>Robinhood's operating model also looks as if it could be easily disrupted. Even though it's best known for attracting retail investors, and the company can generate revenue from certain trading activities, such as options, it generates a good chunk of its revenue from selling order to flow to a small handful of hedge funds and institutional investors. If any of these clients were to stop paying for order flow, or if new regulations altered how order flow was sold, Robinhood could be in big trouble.</p>\n<p><img src=\"https://static.tigerbbs.com/df6ef536d43baa33372dde88018439ea\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<p><b>Aurora Cannabis</b></p>\n<p>Let's face the facts: A majority of Canadian marijuana stocks have no business in investors' portfolios. But time and again <b>Aurora Cannabis</b> (NASDAQ:ACB) has demonstrated that it's one of the worst of the bunch and should be avoided at all costs.</p>\n<p>When Canada legalized recreational weed in October 2018, Aurora looked to be set for success. It eventually held 15 production facilities (many in various stages of development), and anticipated generating a lot of sales via overseas exports. But in the nearly three years since our northerly neighbor waved the green flag on adult-use cannabis, Aurora's international revenue is still minimal, and it's shuttered, sold, or halted construction on more than half of the facilities it once held.</p>\n<p>I can only imagine that one of the more consistently irritating aspects of being an Aurora Cannabis shareholder is the constant dilution. With the former and current management team using the company's shares as collateral to make acquisitions and/or keep the lights on, the company's share count has ballooned from a reverse-split-adjusted 1.3 million to around 198 million in under seven years. With the company racking up 232.3 million Canadian dollars ($185.4 million) in operating losses through the first nine months of fiscal 2021, it's unlikely this share-based dilution is anywhere near finished.</p>\n<p>Want another reason to avoid Aurora? Over the past two years, the company has written down approximately half the value of its total assets (about CA$2.8 billion). It's simply one of the worst stocks to play the cannabis boom.</p>\n<p><img src=\"https://static.tigerbbs.com/07841e6a8173146a0fbfddf95a0f1ccb\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<p><b>GameStop</b></p>\n<p>Since this list of companies to avoid began with a meme stock (AMC), perhaps it's only fitting that it end with another one: <b>GameStop</b> (NYSE:GME).</p>\n<p>Whereas AMC is a fundamental nightmare in every respect, video game and accessories retailer GameStop does at least have a few things working in its favor. For instance, the company was able to raise enough cash to take care of its debt and undertake what'll likely be a multiyear turnaround focused on digital gaming. Additionally, whereas movie theater industry sales are shrinking, digital gaming is expanding, which offers growth opportunities for GameStop.</p>\n<p>The issue, though, is that GameStop is going to take years to turn things around. This is a company that's been built on a brick-and-mortar operating model for more than two decades. As gaming shifts online, GameStop will be forced to close stores at a steady pace to reduce its operating expenses and essentially backpedal its way into the profit column. Though GameStop can be profitable again on a recurring basis, its $15 billion market cap isn't accurately reflective of the challenges that lie ahead.</p>\n<p>If given the choice, I'd choose GameStop over AMC over the long run 1,000 times out of 1,000. But I believe there are much smarter places for investors to put their money right now than a gaming retailer whose sales will likely be stagnant for years.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Ultra-Popular Stocks to Avoid Like the Plague in September</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Ultra-Popular Stocks to Avoid Like the Plague in September\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-07 19:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/07/5-ultra-popular-stocks-avoid-like-plague-september/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Popularity doesn't necessarily translate to profitability on Wall Street.\n\nKey Points\n\nThough the S&P 500 is soaring, the valuations of these stocks make little sense.\n\nFor more than 17 months, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/07/5-ultra-popular-stocks-avoid-like-plague-september/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HOOD":"Robinhood","GME":"游戏驿站","AMC":"AMC院线","ZOM":"Zomedica Pharmaceuticals Corp.","ACB":"奥罗拉大麻公司"},"source_url":"https://www.fool.com/investing/2021/09/07/5-ultra-popular-stocks-avoid-like-plague-september/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2165353911","content_text":"Popularity doesn't necessarily translate to profitability on Wall Street.\n\nKey Points\n\nThough the S&P 500 is soaring, the valuations of these stocks make little sense.\n\nFor more than 17 months, investors have enjoyed a historic bounce-back rally in the stock market. Following the quickest decline of at least 30% in the history of the broad-based S&P 500, the index has since rallied more than 100% off of its low.\nBut just because the market is in rally mode, it doesn't mean every stock deserves its current valuation. The following five ultra-popular stocks are on the radar for all the wrong reasons, and they should be avoided like the plague in September.\n\nImage source: Getty Images.\nAMC Entertainment\nAs I stated last month, movie theater chain AMC Entertainment (NYSE:AMC) will be the top stock to avoid until its share price accurately reflects the ghastly performance of its underlying business and its ugly balance sheet.\nThere pretty much isn't a fundamental factor working in AMC's favor at the moment. Box office ticket sales have consistently been 30% or more below what they were in 2019, and ticket sales had been declining at a fairly steady clip since 2002. CEO Adam Aron has touted AMC's ability to pick up market share during the pandemic, but he overlooks that the actual movie theater pie has been shrinking for two decades.\nMore specific to the company, it burned through close to $577 million in cash in just the first six months of 2021. It's also sitting on $5.5 billion in corporate debt, along with $420 million in deferred rent, all of which will need to be repaid in cash. AMC's cash balance at the end of June was a hair over $1.8 billion, or roughly $2 billion if you include the company's untapped revolving credit line. No matter how you finagle the numbers, AMC has virtually no chance of repaying its obligations, and its bondholders know it, which is why more than $1 billion in combined 2026/2027 maturity bonds are valued at 60% to 65% of face value.\nThe icing on the cake here is that a multitude of theses surrounding an AMC short squeeze aren't supported by fact. Put plainly, a company that was never worth more than $3.8 billion when it was profitable and could pay its debt obligations shouldn't be worth $22 billion when it's hemorrhaging cash and can't pay its obligations.\n\nImage source: Getty Images.\nZomedica\nGenerally speaking, penny stocks (companies with a share price below $5) are penny stocks for a reason. In other words, companies sport a low share price because they're not performing well from an operating standpoint. That's the case with veterinary medicine and diagnostics company Zomedica (NYSEMKT:ZOM).\nOn the surface, there's a lot to like. Pet expenditures in the U.S. haven't declined on a year-over-year basis in more than a quarter of a century, and an estimated $32.3 billion will be spent this year in the U.S. on veterinary care and product sales, according to the American Pet Products Association.  To boot, Zomedica launched its first-ever commercial product in March. Truforma, as it's known, is a point-of-care diagnostics system for cats and dogs.\nThe problem is that Truforma just isn't selling. While the company blamed its commercial launch challenges on the sale of its distribution partner, it's still an eye-opener that the company has managed only $29,817 in total sales since its March launch. Although sales will undoubtedly grow as management works out the kinks, I have to wonder what investor wants to pay a multiple of almost 40 times estimated sales for 2022.\nWith no clear pathway to profitability anytime soon, and management diluting the daylights out of its shareholders to raise cash (there are nearly 980 million outstanding shares), Zomedica is an easy avoid in September.\n\nImage source: Getty Images.\nRobinhood Markets\nAnother ultra-popular stock that should be draped in yellow caution tape for September is online investing app Robinhood Markets (NASDAQ:HOOD).\nOn one hand, Robinhood has seen its user growth blossom since the pandemic began. In the 18-month period between Dec. 31, 2019 and June 30, 2021, the company's funded accounts have grown from about 10 million to 22.5 million. It also now has more than $100 billion in assets under custody. As retail investors have flocked to Robinhood, revenue has soared.\nBut this doesn't tell the full story. Even though its customer count has risen, Robinhood has rubbed retail investors and U.S. regulators the wrong way. The company had to pare back trading activity earlier this year on heavily shorted meme stocks (companies lauded for their social media buzz, rather than their operating performance) because it lacked the capital to support heightened trading activity. It's drawn ire from regulators over its sale of order flow to hedge funds, as well.\nRobinhood's operating model also looks as if it could be easily disrupted. Even though it's best known for attracting retail investors, and the company can generate revenue from certain trading activities, such as options, it generates a good chunk of its revenue from selling order to flow to a small handful of hedge funds and institutional investors. If any of these clients were to stop paying for order flow, or if new regulations altered how order flow was sold, Robinhood could be in big trouble.\n\nImage source: Getty Images.\nAurora Cannabis\nLet's face the facts: A majority of Canadian marijuana stocks have no business in investors' portfolios. But time and again Aurora Cannabis (NASDAQ:ACB) has demonstrated that it's one of the worst of the bunch and should be avoided at all costs.\nWhen Canada legalized recreational weed in October 2018, Aurora looked to be set for success. It eventually held 15 production facilities (many in various stages of development), and anticipated generating a lot of sales via overseas exports. But in the nearly three years since our northerly neighbor waved the green flag on adult-use cannabis, Aurora's international revenue is still minimal, and it's shuttered, sold, or halted construction on more than half of the facilities it once held.\nI can only imagine that one of the more consistently irritating aspects of being an Aurora Cannabis shareholder is the constant dilution. With the former and current management team using the company's shares as collateral to make acquisitions and/or keep the lights on, the company's share count has ballooned from a reverse-split-adjusted 1.3 million to around 198 million in under seven years. With the company racking up 232.3 million Canadian dollars ($185.4 million) in operating losses through the first nine months of fiscal 2021, it's unlikely this share-based dilution is anywhere near finished.\nWant another reason to avoid Aurora? Over the past two years, the company has written down approximately half the value of its total assets (about CA$2.8 billion). It's simply one of the worst stocks to play the cannabis boom.\n\nImage source: Getty Images.\nGameStop\nSince this list of companies to avoid began with a meme stock (AMC), perhaps it's only fitting that it end with another one: GameStop (NYSE:GME).\nWhereas AMC is a fundamental nightmare in every respect, video game and accessories retailer GameStop does at least have a few things working in its favor. For instance, the company was able to raise enough cash to take care of its debt and undertake what'll likely be a multiyear turnaround focused on digital gaming. Additionally, whereas movie theater industry sales are shrinking, digital gaming is expanding, which offers growth opportunities for GameStop.\nThe issue, though, is that GameStop is going to take years to turn things around. This is a company that's been built on a brick-and-mortar operating model for more than two decades. As gaming shifts online, GameStop will be forced to close stores at a steady pace to reduce its operating expenses and essentially backpedal its way into the profit column. Though GameStop can be profitable again on a recurring basis, its $15 billion market cap isn't accurately reflective of the challenges that lie ahead.\nIf given the choice, I'd choose GameStop over AMC over the long run 1,000 times out of 1,000. But I believe there are much smarter places for investors to put their money right now than a gaming retailer whose sales will likely be stagnant for years.","news_type":1},"isVote":1,"tweetType":1,"viewCount":321,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":810450017,"gmtCreate":1629994793039,"gmtModify":1676530196670,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/810450017","repostId":"810659369","repostType":1,"repost":{"id":810659369,"gmtCreate":1629974162248,"gmtModify":1676530188834,"author":{"id":"9000000000000188","authorId":"9000000000000188","name":"ChristopherGonzalez","avatar":"https://static.tigerbbs.com/25de0f9117703019bacf8912f27a152a","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"Isn't this stock at risk of being de-listed?","htmlText":"Isn't this stock at risk of being de-listed? My understanding is that if a stock trades under $1/share for a certain time it is given x amount of time to get their stock price over $1. Also, if the price doesn't rise to $1 + and stay there then don't some companies do a reverse split ??? I am thinking of buying shares but am concerned that the moment I do they will announce the reverse.<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>","listText":"Isn't this stock at risk of being de-listed? My understanding is that if a stock trades under $1/share for a certain time it is given x amount of time to get their stock price over $1. Also, if the price doesn't rise to $1 + and stay there then don't some companies do a reverse split ??? I am thinking of buying shares but am concerned that the moment I do they will announce the reverse.<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>","text":"Isn't this stock at risk of being de-listed? My understanding is that if a stock trades under $1/share for a certain time it is given x amount of time to get their stock price over $1. Also, if the price doesn't rise to $1 + and stay there then don't some companies do a reverse split ??? I am thinking of buying shares but am concerned that the moment I do they will announce the reverse.$Zomedica Pharmaceuticals Corp.(ZOM)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/810659369","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":214,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":810427722,"gmtCreate":1629994785166,"gmtModify":1676530196678,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"Below 20 cents then. Delisted","listText":"Below 20 cents then. Delisted","text":"Below 20 cents then. Delisted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/810427722","repostId":"810659369","repostType":1,"repost":{"id":810659369,"gmtCreate":1629974162248,"gmtModify":1676530188834,"author":{"id":"9000000000000188","authorId":"9000000000000188","name":"ChristopherGonzalez","avatar":"https://static.tigerbbs.com/25de0f9117703019bacf8912f27a152a","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"Isn't this stock at risk of being de-listed?","htmlText":"Isn't this stock at risk of being de-listed? My understanding is that if a stock trades under $1/share for a certain time it is given x amount of time to get their stock price over $1. Also, if the price doesn't rise to $1 + and stay there then don't some companies do a reverse split ??? I am thinking of buying shares but am concerned that the moment I do they will announce the reverse.<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>","listText":"Isn't this stock at risk of being de-listed? My understanding is that if a stock trades under $1/share for a certain time it is given x amount of time to get their stock price over $1. Also, if the price doesn't rise to $1 + and stay there then don't some companies do a reverse split ??? I am thinking of buying shares but am concerned that the moment I do they will announce the reverse.<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>","text":"Isn't this stock at risk of being de-listed? My understanding is that if a stock trades under $1/share for a certain time it is given x amount of time to get their stock price over $1. Also, if the price doesn't rise to $1 + and stay there then don't some companies do a reverse split ??? I am thinking of buying shares but am concerned that the moment I do they will announce the reverse.$Zomedica Pharmaceuticals Corp.(ZOM)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/810659369","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":318,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":837492191,"gmtCreate":1629903621513,"gmtModify":1676530168589,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"Just bought 10k worth of $zom shares","listText":"Just bought 10k worth of $zom shares","text":"Just bought 10k worth of $zom shares","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/837492191","repostId":"1160946939","repostType":4,"repost":{"id":"1160946939","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1629902821,"share":"https://www.laohu8.com/m/news/1160946939?lang=&edition=full","pubTime":"2021-08-25 22:47","market":"us","language":"en","title":"Zomedica Corp shares Popped 12% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1160946939","media":"Tiger Newspress","summary":"Zomedica Corp shares Popped 12% in morning trading.","content":"<p>Zomedica Corp shares Popped 12% in morning trading.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zomedica Corp shares Popped 12% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZomedica Corp shares Popped 12% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-25 22:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zomedica Corp shares Popped 12% in morning trading.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZOM":"Zomedica Pharmaceuticals Corp."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160946939","content_text":"Zomedica Corp shares Popped 12% in morning trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":539,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":833962279,"gmtCreate":1629198408491,"gmtModify":1676529962887,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>yeet","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>yeet","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$yeet","images":[{"img":"https://static.tigerbbs.com/d83ab1bbc1758c53edf96323babf0379","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/833962279","isVote":1,"tweetType":1,"viewCount":443,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":801986400,"gmtCreate":1627479613800,"gmtModify":1703490756541,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>im super bullish on this , going to 5 dollars EOY","listText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>im super bullish on this , going to 5 dollars EOY","text":"$Sundial Growers Inc.(SNDL)$im super bullish on this , going to 5 dollars EOY","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/801986400","isVote":1,"tweetType":1,"viewCount":458,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":800587768,"gmtCreate":1627308740454,"gmtModify":1703487332115,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>hodling till 1.5 price target","listText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>hodling till 1.5 price target","text":"$Sundial Growers Inc.(SNDL)$hodling till 1.5 price target","images":[{"img":"https://static.tigerbbs.com/62e42ba0647287f58e54e275e3cb2c6f","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/800587768","isVote":1,"tweetType":1,"viewCount":401,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":145498126,"gmtCreate":1626234939465,"gmtModify":1703756073664,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>not going to lie","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>not going to lie","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$not going to lie","images":[{"img":"https://static.tigerbbs.com/fddad871950d079100b56a3beb8175ba","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/145498126","isVote":1,"tweetType":1,"viewCount":375,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":146845346,"gmtCreate":1626070230585,"gmtModify":1703752749598,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"It's going to pop soon","listText":"It's going to pop soon","text":"It's going to pop soon","images":[{"img":"https://static.tigerbbs.com/9ec6ab730394ada37097584234882201","width":"1080","height":"2784"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/146845346","isVote":1,"tweetType":1,"viewCount":304,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":146842170,"gmtCreate":1626070166390,"gmtModify":1703752748766,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/WKHS\">$Workhorse(WKHS)$</a>it should hover around 12-13 dollars by end of this week","listText":"<a href=\"https://laohu8.com/S/WKHS\">$Workhorse(WKHS)$</a>it should hover around 12-13 dollars by end of this week","text":"$Workhorse(WKHS)$it should hover around 12-13 dollars by end of this week","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/146842170","isVote":1,"tweetType":1,"viewCount":254,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":143422540,"gmtCreate":1625811381280,"gmtModify":1703749042395,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>HHappy","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>HHappy","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$HHappy","images":[{"img":"https://static.tigerbbs.com/4d3822f7eae4b1fe1394236b43336d6c","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/143422540","isVote":1,"tweetType":1,"viewCount":215,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":157922716,"gmtCreate":1625560850435,"gmtModify":1703743753594,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Truforma is going to change the pet industry","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Truforma is going to change the pet industry","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$Truforma is going to change the pet industry","images":[{"img":"https://static.tigerbbs.com/4998428cdcb4d3418af2ac7d9cb66598","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":5,"repostSize":2,"link":"https://ttm.financial/post/157922716","isVote":1,"tweetType":1,"viewCount":1229,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3578485569204872","authorId":"3578485569204872","name":"EveryTimeIsAGoodTime","avatar":"https://community-static.tradeup.com/news/9163ac5ce8379c394bf24e2cb901d9de","crmLevel":2,"crmLevelSwitch":0},"content":"Zom has unlimited potential in the future","text":"Zom has unlimited potential in the future","html":"Zom has unlimited potential in the future"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":154373689,"gmtCreate":1625484860341,"gmtModify":1703742514403,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>will average down&nbsp;","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>will average down&nbsp;","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$will average down","images":[{"img":"https://static.tigerbbs.com/a05ef1be42ed42c182dfc1a6e1445999","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/154373689","isVote":1,"tweetType":1,"viewCount":92,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":156881367,"gmtCreate":1625210742259,"gmtModify":1703738427398,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"Like and comment to see Tesla to 723 by end of July&nbsp;","listText":"Like and comment to see Tesla to 723 by end of July&nbsp;","text":"Like and comment to see Tesla to 723 by end of July","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/156881367","repostId":"1169411779","repostType":4,"isVote":1,"tweetType":1,"viewCount":373,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":150460791,"gmtCreate":1624924778613,"gmtModify":1703847924208,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"Stock market at all time highs like and comment","listText":"Stock market at all time highs like and comment","text":"Stock market at all time highs like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/150460791","repostId":"2147830544","repostType":4,"repost":{"id":"2147830544","pubTimestamp":1624923000,"share":"https://www.laohu8.com/m/news/2147830544?lang=&edition=full","pubTime":"2021-06-29 07:30","market":"us","language":"en","title":"Stocks making the biggest moves after hours: Morgan Stanley,Goldman Sachs,Luminar and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2147830544","media":"StreetInsider","summary":"After-Hours Stock Movers\nCelcuity Inc. (Nasdaq: CELC) 15.2% LOWER; announced that it has commenced a","content":"<p>After-Hours Stock Movers</p>\n<p><a href=\"https://laohu8.com/S/CELC\">Celcuity Inc</a>. (Nasdaq: CELC) 15.2% LOWER; announced that it has commenced an underwritten public offering of shares of its common stock.</p>\n<p><a href=\"https://laohu8.com/S/BTRS\">BTRS Holdings Inc.</a> (Nasdaq: BTRS) 7.2% LOWER; announced the commencement of an underwritten secondary offering of 9,000,000 shares of the Company’s Class 1 common stock.</p>\n<p><a href=\"https://laohu8.com/S/ALGS\">Aligos Therapeutics, Inc.</a> (Nasdaq: ALGS) 6.6% LOWER; today announced that it has commenced an underwritten public offering of 4,000,000 shares of common stock.</p>\n<p>LiveXLive Media (NASDAQ: LIVX) 3.7% HIGHER; reported Q4 EPS of ($0.20), $0.10 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $21 million versus the consensus estimate of $20.12 million. LiveXLive Media sees FY2022 revenue of $110-120 million, versus the consensus of $101.4 million.</p>\n<p>Herman Miller (NASDAQ: MLHR) 3% LOWER; reported Q4 EPS of $0.56, $0.17 better than the analyst estimate of $0.39. Revenue for the quarter came in at $621.5 million versus the consensus estimate of $583.04 million. Herman Miller sees Q1 2022 EPS of $0.52-$0.58. Herman Miller sees Q1 2022 revenue of $640-670 million.</p>\n<p><a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a> (NYSE: MS) 2.6% HIGHER; announced that it will double its quarterly common stock dividend to $0.70 per share from the current $0.35 per share, beginning with the common dividend expected to be declared by the Firm’s Board of Directors in the third quarter of 2021. In addition, the Firm announced a new increased repurchase authorization of outstanding common stock of up to $12 billion through June 30, 2022.</p>\n<p>Intellia Therapeutics, Inc. (NASDAQ: NTLA) 1.8% LOWER; announced today that it has commenced an underwritten public offering of $400 million of shares of its common stock</p>\n<p>Luminar Technologies (NASDAQ: LAZR) 1.7% LOWER; to offer 9 million shares for selling shareholders President, Chief Executive Officer and Chairman.</p>\n<p>Cadiz Inc. (NASDAQ: CDZI) 1.3% LOWER; commenced an underwritten registered public offering of 2,000,000 depositary shares, each representing a 1/1000th fractional interest in a share of the Company's Series A Cumulative Perpetual Preferred Stock, with a liquidation preference of $25.00 per depositary share, to raise anticipated gross proceeds of $50.0 million before deducting transaction expenses, subject to market and certain other conditions. The Company expects to grant the underwriters a 30-day option to purchase additional depositary shares in connection with the offering.</p>\n<p><a href=\"https://laohu8.com/S/ASAN\">Asana, Inc.</a> (NYSE: ASAN) 1.2% HIGHER; CEO, Dustin Moskovitz, bought 320,000 shares from 06/24-06/25 at prices from $59.20-$63.52. The value of the purchases is about $20 million.</p>\n<p>The <a href=\"https://laohu8.com/S/GSJ.CL\">Goldman Sachs Group, Inc.</a> (NYSE: GS) 1.1% HIGHER; announced planned increase in the common stock dividend from $1.25 to $2.00 per share</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks making the biggest moves after hours: Morgan Stanley,Goldman Sachs,Luminar and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks making the biggest moves after hours: Morgan Stanley,Goldman Sachs,Luminar and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 07:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18615689><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers\nCelcuity Inc. (Nasdaq: CELC) 15.2% LOWER; announced that it has commenced an underwritten public offering of shares of its common stock.\nBTRS Holdings Inc. (Nasdaq: BTRS) 7.2%...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18615689\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BTRS":"BTRS Holdings Inc.","MS":"摩根士丹利","CELC":"Celcuity Inc","GS":"高盛","ALGS":"Aligos Therapeutics, Inc."},"source_url":"https://www.streetinsider.com/dr/news.php?id=18615689","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2147830544","content_text":"After-Hours Stock Movers\nCelcuity Inc. (Nasdaq: CELC) 15.2% LOWER; announced that it has commenced an underwritten public offering of shares of its common stock.\nBTRS Holdings Inc. (Nasdaq: BTRS) 7.2% LOWER; announced the commencement of an underwritten secondary offering of 9,000,000 shares of the Company’s Class 1 common stock.\nAligos Therapeutics, Inc. (Nasdaq: ALGS) 6.6% LOWER; today announced that it has commenced an underwritten public offering of 4,000,000 shares of common stock.\nLiveXLive Media (NASDAQ: LIVX) 3.7% HIGHER; reported Q4 EPS of ($0.20), $0.10 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $21 million versus the consensus estimate of $20.12 million. LiveXLive Media sees FY2022 revenue of $110-120 million, versus the consensus of $101.4 million.\nHerman Miller (NASDAQ: MLHR) 3% LOWER; reported Q4 EPS of $0.56, $0.17 better than the analyst estimate of $0.39. Revenue for the quarter came in at $621.5 million versus the consensus estimate of $583.04 million. Herman Miller sees Q1 2022 EPS of $0.52-$0.58. Herman Miller sees Q1 2022 revenue of $640-670 million.\nMorgan Stanley (NYSE: MS) 2.6% HIGHER; announced that it will double its quarterly common stock dividend to $0.70 per share from the current $0.35 per share, beginning with the common dividend expected to be declared by the Firm’s Board of Directors in the third quarter of 2021. In addition, the Firm announced a new increased repurchase authorization of outstanding common stock of up to $12 billion through June 30, 2022.\nIntellia Therapeutics, Inc. (NASDAQ: NTLA) 1.8% LOWER; announced today that it has commenced an underwritten public offering of $400 million of shares of its common stock\nLuminar Technologies (NASDAQ: LAZR) 1.7% LOWER; to offer 9 million shares for selling shareholders President, Chief Executive Officer and Chairman.\nCadiz Inc. (NASDAQ: CDZI) 1.3% LOWER; commenced an underwritten registered public offering of 2,000,000 depositary shares, each representing a 1/1000th fractional interest in a share of the Company's Series A Cumulative Perpetual Preferred Stock, with a liquidation preference of $25.00 per depositary share, to raise anticipated gross proceeds of $50.0 million before deducting transaction expenses, subject to market and certain other conditions. The Company expects to grant the underwriters a 30-day option to purchase additional depositary shares in connection with the offering.\nAsana, Inc. (NYSE: ASAN) 1.2% HIGHER; CEO, Dustin Moskovitz, bought 320,000 shares from 06/24-06/25 at prices from $59.20-$63.52. The value of the purchases is about $20 million.\nThe Goldman Sachs Group, Inc. (NYSE: GS) 1.1% HIGHER; announced planned increase in the common stock dividend from $1.25 to $2.00 per share","news_type":1},"isVote":1,"tweetType":1,"viewCount":184,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":128682313,"gmtCreate":1624513744432,"gmtModify":1703838980512,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"30 days ma looks good. Get ready for a strong rebound after it clears its debt structure","listText":"30 days ma looks good. Get ready for a strong rebound after it clears its debt structure","text":"30 days ma looks good. Get ready for a strong rebound after it clears its debt structure","images":[{"img":"https://static.tigerbbs.com/3ed316f192c358719a19f60655f37d13","width":"1080","height":"1968"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/128682313","isVote":1,"tweetType":1,"viewCount":224,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":128681737,"gmtCreate":1624513678229,"gmtModify":1703838975405,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"Breaking news indeed","listText":"Breaking news indeed","text":"Breaking news indeed","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/128681737","repostId":"1148268309","repostType":4,"isVote":1,"tweetType":1,"viewCount":45,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":128683229,"gmtCreate":1624513645661,"gmtModify":1703838973275,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>downwards trend but&nbsp;I know it will spring back up like a spring board","listText":"<a href=\"https://laohu8.com/S/XELA\">$Exela Technologies, Inc.(XELA)$</a>downwards trend but&nbsp;I know it will spring back up like a spring board","text":"$Exela Technologies, Inc.(XELA)$downwards trend but I know it will spring back up like a spring board","images":[{"img":"https://static.tigerbbs.com/7b5fc2cf6fdabc3de4d2d814f9194141","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/128683229","isVote":1,"tweetType":1,"viewCount":145,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"hots":[{"id":157922716,"gmtCreate":1625560850435,"gmtModify":1703743753594,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Truforma is going to change the pet industry","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>Truforma is going to change the pet industry","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$Truforma is going to change the pet industry","images":[{"img":"https://static.tigerbbs.com/4998428cdcb4d3418af2ac7d9cb66598","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":5,"repostSize":2,"link":"https://ttm.financial/post/157922716","isVote":1,"tweetType":1,"viewCount":1229,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3578485569204872","authorId":"3578485569204872","name":"EveryTimeIsAGoodTime","avatar":"https://community-static.tradeup.com/news/9163ac5ce8379c394bf24e2cb901d9de","crmLevel":2,"crmLevelSwitch":0},"content":"Zom has unlimited potential in the future","text":"Zom has unlimited potential in the future","html":"Zom has unlimited potential in the future"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9952696483,"gmtCreate":1674665763142,"gmtModify":1676538951858,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://ttm.financial/OPT/BOIL 20230203 11.0 CALL\">$BOIL 20230203 11.0 CALL$ </a><a href=\"https://ttm.financial/OPT/BOIL 20230203 11.0 CALL\">$BOIL 20230203 11.0 CALL$&nbsp;</a> &nbsp;","listText":"<a href=\"https://ttm.financial/OPT/BOIL 20230203 11.0 CALL\">$BOIL 20230203 11.0 CALL$ </a><a href=\"https://ttm.financial/OPT/BOIL 20230203 11.0 CALL\">$BOIL 20230203 11.0 CALL$&nbsp;</a> &nbsp;","text":"$BOIL 20230203 11.0 CALL$ $BOIL 20230203 11.0 CALL$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9952696483","isVote":1,"tweetType":1,"viewCount":257,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":800587768,"gmtCreate":1627308740454,"gmtModify":1703487332115,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>hodling till 1.5 price target","listText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>hodling till 1.5 price target","text":"$Sundial Growers Inc.(SNDL)$hodling till 1.5 price target","images":[{"img":"https://static.tigerbbs.com/62e42ba0647287f58e54e275e3cb2c6f","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/800587768","isVote":1,"tweetType":1,"viewCount":401,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":135273471,"gmtCreate":1622167099893,"gmtModify":1704180725491,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"Please like and comment","listText":"Please like and comment","text":"Please like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/135273471","repostId":"2138942172","repostType":4,"isVote":1,"tweetType":1,"viewCount":200,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":185219993,"gmtCreate":1623652039912,"gmtModify":1704207865778,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"Like and comment&nbsp;","listText":"Like and comment&nbsp;","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/185219993","repostId":"1105297799","repostType":4,"repost":{"id":"1105297799","pubTimestamp":1623626792,"share":"https://www.laohu8.com/m/news/1105297799?lang=&edition=full","pubTime":"2021-06-14 07:26","market":"us","language":"en","title":"A Meme Stock Is Born: How to Spot the Next Reddit Favorite","url":"https://stock-news.laohu8.com/highlight/detail?id=1105297799","media":"Bloomberg","summary":"Heavily shorted shares are a common theme among the group. The big stock-price gains often come alongside big drops. While there’s no steadfast definition of what constitutes a meme stock, one common thread across the many names being pitched on social media is a focus on heavily shorted companies. Shares of Reddit iconGameStop Corp.jumped as much as 2,500% in January after day traders noticed its short interest had ballooned to record levels.“I can’t imagine this is going to continue in the sam","content":"<ul>\n <li>Heavily shorted shares are a common theme among the group</li>\n <li>The big stock-price gains often come alongside big drops</li>\n</ul>\n<p>Trying to keep up with the frenzied rise of so-called meme stocks mightfeela bit like playing a game of whack-a-mole, bewildering analysts and investors alike.</p>\n<p>While there’s no steadfast definition of what constitutes a meme stock, one common thread across the many names being pitched on social media is a focus on heavily shorted companies. Shares of Reddit iconGameStop Corp.jumped as much as 2,500% in January after day traders noticed its short interest had ballooned to record levels.</p>\n<p>Investors looking for other stocks that might fit that mold will find nearly 230 firms with a market capitalization of at least $100 million and short interest of 15% or more, according to S3 Partners data compiled by Bloomberg. More than 80% of those names have managed positive returns over the last month with the average gain sitting at about 18%, while the S&amp;P 500 Index rose 2.3%.</p>\n<p><img src=\"https://static.tigerbbs.com/3cc5569937ba7f5b5c78898800cdfdfc\" tg-width=\"773\" tg-height=\"717\"></p>\n<p>Among the most heavily shorted stocks are names like&nbsp;Clover Health Investments Corp.,Workhorse Group Inc.&nbsp;and&nbsp;Geo Group Inc., which have already caught the attention of retail traders in recent days.</p>\n<p>Meanwhile,Bumble Inc.&nbsp;and&nbsp;Petco Health and Wellness Co., both fresh off initial public offerings this year, find themselves on the outside looking in as part of the few companies on the list that haven’t seen outsized gains over the last month. Joining them is ad-tech firmPubMatic Inc., which boasts the highest short interest at 54%, recreational boat retailer MarineMax Inc. and biotech companyBlack Diamond Therapeutics Inc., which has plunged more than 50% over the last month.</p>\n<p><img src=\"https://static.tigerbbs.com/dd6a19a4330894a2f8dfe602f1f76c6a\" tg-width=\"773\" tg-height=\"737\"></p>\n<p>While these sudden rallies can create lucrative returns for investors in the blink of an eye, the extreme volatility that accompanies them can quickly catch traders offside, leaving them holding the bag as shares plunge back to earth.</p>\n<p>After opening the week with a 32% gain, Clover Health’s shares jumped by as much as 142% over the next two days. But, by the close of trading Thursday, anyone who had bought and held shares after Monday’s pop was now underwater.</p>\n<p><img src=\"https://static.tigerbbs.com/bb51208dc3df58cd52f6d1a876bdf594\" tg-width=\"1200\" tg-height=\"675\"></p>\n<p>“I can’t imagine this is going to continue in the same form or fashion for much longer,” said Barry Schwartz, chief investment officer at Baskin Wealth Management. “Just because something is shorted doesn’t mean buying it is going to work out for you,” he added. “You’re playing with fire.”</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Meme Stock Is Born: How to Spot the Next Reddit Favorite</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Meme Stock Is Born: How to Spot the Next Reddit Favorite\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-14 07:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-13/a-meme-stock-is-born-how-to-spot-the-next-reddit-favorite?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Heavily shorted shares are a common theme among the group\nThe big stock-price gains often come alongside big drops\n\nTrying to keep up with the frenzied rise of so-called meme stocks mightfeela bit ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-13/a-meme-stock-is-born-how-to-spot-the-next-reddit-favorite?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"WKHS":"Workhorse Group, Inc.","WOOF":"Petco Health and Wellness Company, Inc.",".DJI":"道琼斯",".IXIC":"NASDAQ Composite","GEO":"GEO惩教集团","BMBL":"Bumble Inc.",".SPX":"S&P 500 Index","KWITD":"Wellness Matrix Group, Inc.","CLOV":"Clover Health Corp"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-13/a-meme-stock-is-born-how-to-spot-the-next-reddit-favorite?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105297799","content_text":"Heavily shorted shares are a common theme among the group\nThe big stock-price gains often come alongside big drops\n\nTrying to keep up with the frenzied rise of so-called meme stocks mightfeela bit like playing a game of whack-a-mole, bewildering analysts and investors alike.\nWhile there’s no steadfast definition of what constitutes a meme stock, one common thread across the many names being pitched on social media is a focus on heavily shorted companies. Shares of Reddit iconGameStop Corp.jumped as much as 2,500% in January after day traders noticed its short interest had ballooned to record levels.\nInvestors looking for other stocks that might fit that mold will find nearly 230 firms with a market capitalization of at least $100 million and short interest of 15% or more, according to S3 Partners data compiled by Bloomberg. More than 80% of those names have managed positive returns over the last month with the average gain sitting at about 18%, while the S&P 500 Index rose 2.3%.\n\nAmong the most heavily shorted stocks are names like Clover Health Investments Corp.,Workhorse Group Inc. and Geo Group Inc., which have already caught the attention of retail traders in recent days.\nMeanwhile,Bumble Inc. and Petco Health and Wellness Co., both fresh off initial public offerings this year, find themselves on the outside looking in as part of the few companies on the list that haven’t seen outsized gains over the last month. Joining them is ad-tech firmPubMatic Inc., which boasts the highest short interest at 54%, recreational boat retailer MarineMax Inc. and biotech companyBlack Diamond Therapeutics Inc., which has plunged more than 50% over the last month.\n\nWhile these sudden rallies can create lucrative returns for investors in the blink of an eye, the extreme volatility that accompanies them can quickly catch traders offside, leaving them holding the bag as shares plunge back to earth.\nAfter opening the week with a 32% gain, Clover Health’s shares jumped by as much as 142% over the next two days. But, by the close of trading Thursday, anyone who had bought and held shares after Monday’s pop was now underwater.\n\n“I can’t imagine this is going to continue in the same form or fashion for much longer,” said Barry Schwartz, chief investment officer at Baskin Wealth Management. “Just because something is shorted doesn’t mean buying it is going to work out for you,” he added. “You’re playing with fire.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":65,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3583106612879478","authorId":"3583106612879478","name":"DylanYii","avatar":"https://static.tigerbbs.com/63bdc7c51b67ab113984a8ecc77b3917","crmLevel":1,"crmLevelSwitch":0},"content":"Done pls reply baCk","text":"Done pls reply baCk","html":"Done pls reply baCk"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":128681737,"gmtCreate":1624513678229,"gmtModify":1703838975405,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"Breaking news indeed","listText":"Breaking news indeed","text":"Breaking news indeed","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/128681737","repostId":"1148268309","repostType":4,"repost":{"id":"1148268309","pubTimestamp":1624513156,"share":"https://www.laohu8.com/m/news/1148268309?lang=&edition=full","pubTime":"2021-06-24 13:39","market":"us","language":"en","title":"The ‘incredible’ U.S. tech stocks to buy when there’s a dip: Investor","url":"https://stock-news.laohu8.com/highlight/detail?id=1148268309","media":"CNBC","summary":"There’s still an opportunity in certain technology stocks — even with the sector’s high valuations —","content":"<div>\n<p>There’s still an opportunity in certain technology stocks — even with the sector’s high valuations — but only if investors wait for a “significant dip,” one chief investment officer has told CNBC.\n...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/24/the-incredible-us-tech-stocks-to-buy-when-theres-a-dip-investor.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The ‘incredible’ U.S. tech stocks to buy when there’s a dip: Investor</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe ‘incredible’ U.S. tech stocks to buy when there’s a dip: Investor\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 13:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/24/the-incredible-us-tech-stocks-to-buy-when-theres-a-dip-investor.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There’s still an opportunity in certain technology stocks — even with the sector’s high valuations — but only if investors wait for a “significant dip,” one chief investment officer has told CNBC.\n...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/24/the-incredible-us-tech-stocks-to-buy-when-theres-a-dip-investor.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GOOG":"谷歌","AMZN":"亚马逊","AAPL":"苹果","NFLX":"奈飞"},"source_url":"https://www.cnbc.com/2021/06/24/the-incredible-us-tech-stocks-to-buy-when-theres-a-dip-investor.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1148268309","content_text":"There’s still an opportunity in certain technology stocks — even with the sector’s high valuations — but only if investors wait for a “significant dip,” one chief investment officer has told CNBC.\nPrivate bank Kleinwort Hambros’ CIO Fahad Kamal named his favorite Big Tech stocks to buy when the price is right, despite the shift in focus to so-called “value” stocks.\nValue stocks are viewed as undervalued by investors and are expected to benefit from the economic recovery after the pandemic. Growth stocks, on the other hand, include the major tech stocks and are considered to be companies with revenues and earnings that are expected to grow at a faster rate than the rest of the market.However, they can prove riskier and more volatile.\nThe technology-focused U.S. Nasdaq index hit fresh highs this year, but has still seen some sharp dips since the beginning of 2021. Last week, the Nasdaq fell close to 2%.\nSpeaking to “Squawk Box Europe” Friday, Kamal highlighted a key group of technology stocks that he said would be best to buy in a market dip.\nHe said the “big five” —Facebook,Apple,Amazon,Netflix and Google, also known as the FAANGs —  remained “incredible companies.” He highlighted that they had each reported strong earnings in the first quarter of 2021, despite coming from “record positions.”\nFor example, social media giant Facebook reported that its net income grew 94%to $9.5 billion in the first quarter, whileApple posted its best-ever quarterly revenueof $111.4 billion in the first three months of fiscal 2021.\n“I mean it’s incredible, these remain incredible companies, they are going to be setting the tone for markets for the foreseeable future, there’s no doubt about that,” Kamal said.\nHe acknowledged that they still looked expensive when compared to other stocks, but encouraged investors to look for an entry point in a “significant dip” to buy into these companies.\nPrice-to-earnings is one gauge as to how expensive a stock is. Amazon has a ratio of 66 and Netflix has a ratio of 62, while the average across theDowis just under 22.\nNot everyone is convinced, however. Adam Parker, founder of Trivariate Research, warned that some big tech stocks are high risk and should be treated with caution. Apple made Trivariate’s list of riskiest stocks; the research firm said it had the most negative correlation to inflation.\nKleinwort Hambros has had a “long-standing overweight” position on “growth” stocks for the last five or six years, Kamal said, particularly technology firms.\nMore recently, he said his firm had lowered its exposure to a more “neutral” position on the sector and invested more in “pro-cyclical regions.” These are investments that are expected to rise and fall with the economic cycle.\nHowever, Kamal stressed that this didn’t mean his firm had sold out of their investments in the technology space but had ” re-positioned slightly because we think that there is catch-up for the value trade still.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":45,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":837492191,"gmtCreate":1629903621513,"gmtModify":1676530168589,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"Just bought 10k worth of $zom shares","listText":"Just bought 10k worth of $zom shares","text":"Just bought 10k worth of $zom shares","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/837492191","repostId":"1160946939","repostType":4,"isVote":1,"tweetType":1,"viewCount":539,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166141733,"gmtCreate":1623998829022,"gmtModify":1703826149463,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"Have not read but please like and comment","listText":"Have not read but please like and comment","text":"Have not read but please like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/166141733","repostId":"1175693382","repostType":4,"repost":{"id":"1175693382","pubTimestamp":1623978463,"share":"https://www.laohu8.com/m/news/1175693382?lang=&edition=full","pubTime":"2021-06-18 09:07","market":"us","language":"en","title":"Alibaba Stock: The Bottoming Process Looks To Be Forming Already","url":"https://stock-news.laohu8.com/highlight/detail?id=1175693382","media":"seekingalpha","summary":"Alibaba is probably the most undervalued growth stock right now.The company’s multiple growth drivers within a rapidly expanding market made its valuations look even more baffling.The short term technical picture may be turning bullish with a potential double bottom price action signal.When we take things into clearer perspective by comparing China’s growth rate and size of its market to that of the U.S. e-commerce market, we could see the huge differences in their sizes and growth rates as the ","content":"<p><b>Summary</b></p>\n<ul>\n <li>Alibaba is probably the most undervalued growth stock right now.</li>\n <li>The company’s multiple growth drivers within a rapidly expanding market made its valuations look even more baffling.</li>\n <li>The short term technical picture may be turning bullish with a potential double bottom price action signal.</li>\n <li>We discuss the company’s multiple growth drivers and let investors judge for themselves.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/05e63c77d4f3f3dc3d618e43044638bb\" tg-width=\"768\" tg-height=\"512\"><span>Yongyuan Dai/iStock Unreleased via Getty Images</span></p>\n<p><b>The Technical Thesis</b></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7febf6ed056b0e3bc038321cdaad9b1c\" tg-width=\"1280\" tg-height=\"782\"><span>Source: TradingView</span></p>\n<p>Alibaba’s&nbsp;stock price has endured a terrible 8 months ever since its Ant Financial IPO was pulled in early Nov 20, with the stock languishing in the doldrums 34% off its high. When considering the health of its long term uptrend, it’s clear that BABA has a relatively strong uptrend bias and has generally been well supported along its key 50W MA. The only other time in the last 4 years that it lost its key 50W MA support level was during the 2018 bear market where BABA dropped about 40%, but was still well supported above the important 200W MA, which we usually consider as the “last line of defense”. Right now BABA is somewhat facing a similar situation again: down 34%, lost the 50W MA, but looks to be well supported above the 200W MA. In addition to that, one interesting observation in price action analysis may lead price action traders/investors to be especially bullish: a potential double bottom formation. BABA's price is seemingly going through a double bottom like it did during the 2018 bear market before it rallied strongly thereafter. As a result, BABA’s current level may offer a possible technical buy entry point now.</p>\n<p><b>BABA's Fundamental Thesis: Rapidly Expanding Growth Drivers</b></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/eba49f5881708929949c30628eedc5d4\" tg-width=\"934\" tg-height=\"578\"><span>Annual GMV. Data source: Company filings</span></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a4d6c4ed3e2402f5af52b2dea8bab411\" tg-width=\"836\" tg-height=\"517\"><span>Annual e-commerce revenue. Data source: Company filings</span></p>\n<p>BABA’s GMV grew from 1.68T yuan to 7.49T yuan in just a matter of 7 years, which represented a CAGR of 23.8%, a truly amazing growth rate. We also saw its GMV growth being converted into revenue growth as its China commerce revenue grew from 7.67B yuan to 473.68B yuan, at a CAGR of 51% over the last 10 years. While its international footprint remains considerably smaller, it still grew at a CAGR of 30.42% over the last 10 years, which was by no means slow.</p>\n<p>Even though China’s e-commerce market is expected to grow considerably slower at a CAGR of 12.4% over the next three years, from 13.8T yuan, equivalent to $2.16T in 2021 to 19.6T yuan,equivalent to $3.06T by 2024, the massive size of the market still offers tremendous upside potential for BABA and its closest competitors to grow into.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ffe2dee43f267e1d1399c68e3ca60f36\" tg-width=\"600\" tg-height=\"371\"><span>E-commerce revenue in the U.S. Data source: Statista</span></p>\n<p>When we take things into clearer perspective by comparing China’s growth rate and size of its market to that of the U.S. e-commerce market, we could see the huge differences in their sizes and growth rates as the U.S. e-commerce market is only expected to grow at a CAGR of 4.67% from 2021 to 2025, which is significantly slower than China’s 12.4%. In addition, the U.S. market is also expected to reach about $563B in total revenue, which is 18% of what the China market is expected to be worth by then.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0d5a8d0d8a6a2dcdf667a6f33c6c9771\" tg-width=\"1280\" tg-height=\"702\"><span>Peers EBIT Margin and Projected EBIT Margin. Data source: S&amp;P Capital IQ</span></p>\n<p>Even though Alibaba has been facing increased competitive pressures from its fast growing key competitors: JD.com(NASDAQ:JD)and Pinduoduo(NASDAQ:PDD), BABA has already been operating a much more profitable business (both EBIT and FCF), and is expected to continue delivering strong profitability moving forward, which should give the company tremendous flexibility to compete head on with JD and PDD in its quest to extend its leadership. Investors may observe that BABA’s EBIT margin was affected by the one-off administrative penalty of $2,782M that was reflected in its SG&amp;A, and therefore skewed its EBIT margin to the downside.</p>\n<p>One important move was the company’s decision to further its investment in the Community Marketplace, which is PDD’s main e-commerce strategy that saw PDD gain a total of&nbsp;823M AAC&nbsp;in its latest quarter as compared to BABA’s 891M AAC. PDD’s AAC growth is truly phenomenal considering it had only&nbsp;100M AAC in Q2’C17&nbsp;as compared to BABA’s 466M AAC in the same period.</p>\n<p>Therefore, the momentum of growth has surely swung over to the Community Marketplace segment and BABA would need to pull out its big guns (which it has) to compete for dominance with PDD and JD.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3b83b69b08b1f4b11a26393c8e6eead5\" tg-width=\"600\" tg-height=\"371\"><span>Market size of community group buying in China. Data source: iiMedia Research</span></p>\n<p>Even though the expected total market size of 102B yuan by 2022 represented only about 21.5% of BABA’s FY 21 China commerce revenue, the expected rapid CAGR of 44.22% over 3 years from 2019 to 2022 cannot be missed by BABA. Although the market is still relatively small, BABA cannot allow the current leader in this market: PDD to so easily dominate and gobble up the early high growth rates at the ignorance of everyone else. Certainly BABA must compete and fight for its place in this segment and strive for early leadership to prevent PDD from extending its lead.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b97b2b4a8a182dc9846d8fb7e4039877\" tg-width=\"1280\" tg-height=\"770\"><span>PDD profitability metrics &amp; revenue growth forecast. Data source: S&amp;P Capital IQ</span></p>\n<p>We could observe from the above chart that PDD is expected to continue growing its revenue rapidly over the next few years, even though they are expected to normalize subsequently. More importantly, PDD is also expected to increasingly improve its EBIT and FCF profitability moving forward. This shows that the Community Marketplace segment is an highly important growth driver that BABA must use its strength to exploit in order to deny PDD’s claim to undisputed leadership so early on in the game.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3aadc32155b4108426a1a982e3b5b1c2\" tg-width=\"640\" tg-height=\"360\"><span>China public cloud spending. Source:China Internet Watch; Canalys</span></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1c1538b9f7bdc8d6d35a72d9acf8ecbc\" tg-width=\"600\" tg-height=\"371\"><span>Size of China public cloud market. Data source: CAICT; Sina.com.cn</span></p>\n<p>BABA has a 40% share in China’s public cloud market, way ahead of its key competitors. However, it’s important to note that despite this leadership, BABA is still in heavy investment mode to continue growing its market share as China’s public cloud market is expected to grow from 26.48B yuan in 2017 to 230.74B yuan by 2023, which would represent a CAGR of 43.4%, an incredibly stellar growth rate. This is especially clear when we compare China’s growth rate to the worldwide growth rate (see below) as public cloud spending worldwide is expected to grow from $145B in 2017 to $397B by 2022, that would represent a CAGR of 22.3%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/06198c569504bc303c34563041dfb294\" tg-width=\"600\" tg-height=\"371\"><span>Worldwide public cloud spending. Data source: Gartner</span></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8482037f60575f964053ab732496bee3\" tg-width=\"1176\" tg-height=\"700\"><span>Worldwide public cloud market share. Source:CnTechPost; Gartner</span></p>\n<p>Therefore, I don’t find it surprising that Ali Cloud has continued to extend its lead over Alphabet’s(NASDAQ:GOOGL)(NASDAQ:GOOG)GCP with a market share of 9.5% in 2020. While AMZN remains the clear leader in the market, its market share has been coming down considerably as public cloud spending continues to expand, indicating that there is a huge potential for growth for multiple players to exist. With BABA’s leadership in the rapidly expanding Chinese market, I’m increasingly bullish on the future profit and FCF contribution from this segment to BABA’s performance over time. Although BABA’s cloud segment has not been EBIT profitable yet (FY 21 EBIT margin: -15%, FY 20 EBIT margin: -17.5%), it’s also useful to note that GCP has also not been profitable for Alphabet as well (FY 20 EBIT margin: -42.9%, FY 19 EBIT margin: -52%). Therefore, we need to give BABA some time to scale up its cloud services in APAC and in China where it is expected to have stronger leadership to allow it to grow faster and investors should expect this to be a highly profitable segment over time.</p>\n<p><b>BABA's Valuations Look Highly Compelling</b></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/62a087c4b3ef7efc2c5dde813e3b959d\" tg-width=\"1000\" tg-height=\"600\"><span>NTM TEV / EBIT 3Y range.</span></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b2605c0e5ad364a7a43929fef204595c\" tg-width=\"1280\" tg-height=\"687\"><span>EV / Fwd EBIT and EV / Fwd Rev trend. Data source: S&amp;P Capital IQ</span></p>\n<p>When we consider BABA's TEV / EBIT historical range, where the 3Y mean read 33.54x, BABA’s EV / Fwd EBIT trend certainly imply a hugely undervalued stock as BABA is still expected to grow its revenue and operating profits rapidly. However, as we wanted to obtain greater clarity over how its counterparts are also valued, we thought it would be useful if we value BABA’s EBIT over a set of benchmark companies that is presented below.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d27873e676dfb23c98d4a69aa5861e02\" tg-width=\"1280\" tg-height=\"1117\"><span>Peers EV / EBIT Valuations. Data source: S&amp;P Capital IQ</span></p>\n<p>By using a blend of historical and forward EBIT, we could see that BABA’s EV / EBIT really looks undervalued when compared to the median value of the set of observed values from the benchmark companies. We derived a fair value range for BABA of $294.98 at the midpoint of the range, that represented a potential upside of 40.5% based on the current stock price of $210.</p>\n<p><b>Risks to Assumptions</b></p>\n<p>Now, it’s obviously baffling to watch how Mr. Market has decided to discount BABA to such an extent as if the company has lost all its key sources of growth, when in fact there is still so much potential upside coming from its commerce segment, the new marketplace initiatives and its growing Ali Cloud segment, among others. The main realistic reason that we identified for the stock's underperformance would simply be regulatory risk. We think investors should acknowledge that this risk is very real and at times huge Chinese companies have found themselves to be subjected to extra scrutiny (which is nothing new in fact) by the Chinese government. What’s critical here is that the Chinese government seemingly has significant clout over the behavior and actions of their tech behemoths that at times may be largely unpredictable. The market certainly hates unpredictability and therefore they may have significantly discounted BABA as a result of that. If investors are not able to handle uncertainty with regard to potentially unpredictable regulatory actions and their aftermath, then BABA may not be appropriate for you. However, if you believe that this is just a blip in BABA’s long journey, then you would surely find BABA's valuations extremely attractive right now, coupled with a long term mindset.</p>\n<p><b>Wrapping It All Up</b></p>\n<p>Alibaba has continued to deliver solid results that demonstrated the strong capability of the company to execute well. As the company continues to operate within a market with so many growth drivers that are expected to drive the company’s future growth, investors should find the current valuations highly attractive.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba Stock: The Bottoming Process Looks To Be Forming Already</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba Stock: The Bottoming Process Looks To Be Forming Already\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 09:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4435297-alibaba-stock-bottoming-process-forming-buy-now><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nAlibaba is probably the most undervalued growth stock right now.\nThe company’s multiple growth drivers within a rapidly expanding market made its valuations look even more baffling.\nThe short...</p>\n\n<a href=\"https://seekingalpha.com/article/4435297-alibaba-stock-bottoming-process-forming-buy-now\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BABA":"阿里巴巴","09988":"阿里巴巴-SW"},"source_url":"https://seekingalpha.com/article/4435297-alibaba-stock-bottoming-process-forming-buy-now","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1175693382","content_text":"Summary\n\nAlibaba is probably the most undervalued growth stock right now.\nThe company’s multiple growth drivers within a rapidly expanding market made its valuations look even more baffling.\nThe short term technical picture may be turning bullish with a potential double bottom price action signal.\nWe discuss the company’s multiple growth drivers and let investors judge for themselves.\n\nYongyuan Dai/iStock Unreleased via Getty Images\nThe Technical Thesis\nSource: TradingView\nAlibaba’s stock price has endured a terrible 8 months ever since its Ant Financial IPO was pulled in early Nov 20, with the stock languishing in the doldrums 34% off its high. When considering the health of its long term uptrend, it’s clear that BABA has a relatively strong uptrend bias and has generally been well supported along its key 50W MA. The only other time in the last 4 years that it lost its key 50W MA support level was during the 2018 bear market where BABA dropped about 40%, but was still well supported above the important 200W MA, which we usually consider as the “last line of defense”. Right now BABA is somewhat facing a similar situation again: down 34%, lost the 50W MA, but looks to be well supported above the 200W MA. In addition to that, one interesting observation in price action analysis may lead price action traders/investors to be especially bullish: a potential double bottom formation. BABA's price is seemingly going through a double bottom like it did during the 2018 bear market before it rallied strongly thereafter. As a result, BABA’s current level may offer a possible technical buy entry point now.\nBABA's Fundamental Thesis: Rapidly Expanding Growth Drivers\nAnnual GMV. Data source: Company filings\nAnnual e-commerce revenue. Data source: Company filings\nBABA’s GMV grew from 1.68T yuan to 7.49T yuan in just a matter of 7 years, which represented a CAGR of 23.8%, a truly amazing growth rate. We also saw its GMV growth being converted into revenue growth as its China commerce revenue grew from 7.67B yuan to 473.68B yuan, at a CAGR of 51% over the last 10 years. While its international footprint remains considerably smaller, it still grew at a CAGR of 30.42% over the last 10 years, which was by no means slow.\nEven though China’s e-commerce market is expected to grow considerably slower at a CAGR of 12.4% over the next three years, from 13.8T yuan, equivalent to $2.16T in 2021 to 19.6T yuan,equivalent to $3.06T by 2024, the massive size of the market still offers tremendous upside potential for BABA and its closest competitors to grow into.\nE-commerce revenue in the U.S. Data source: Statista\nWhen we take things into clearer perspective by comparing China’s growth rate and size of its market to that of the U.S. e-commerce market, we could see the huge differences in their sizes and growth rates as the U.S. e-commerce market is only expected to grow at a CAGR of 4.67% from 2021 to 2025, which is significantly slower than China’s 12.4%. In addition, the U.S. market is also expected to reach about $563B in total revenue, which is 18% of what the China market is expected to be worth by then.\nPeers EBIT Margin and Projected EBIT Margin. Data source: S&P Capital IQ\nEven though Alibaba has been facing increased competitive pressures from its fast growing key competitors: JD.com(NASDAQ:JD)and Pinduoduo(NASDAQ:PDD), BABA has already been operating a much more profitable business (both EBIT and FCF), and is expected to continue delivering strong profitability moving forward, which should give the company tremendous flexibility to compete head on with JD and PDD in its quest to extend its leadership. Investors may observe that BABA’s EBIT margin was affected by the one-off administrative penalty of $2,782M that was reflected in its SG&A, and therefore skewed its EBIT margin to the downside.\nOne important move was the company’s decision to further its investment in the Community Marketplace, which is PDD’s main e-commerce strategy that saw PDD gain a total of 823M AAC in its latest quarter as compared to BABA’s 891M AAC. PDD’s AAC growth is truly phenomenal considering it had only 100M AAC in Q2’C17 as compared to BABA’s 466M AAC in the same period.\nTherefore, the momentum of growth has surely swung over to the Community Marketplace segment and BABA would need to pull out its big guns (which it has) to compete for dominance with PDD and JD.\nMarket size of community group buying in China. Data source: iiMedia Research\nEven though the expected total market size of 102B yuan by 2022 represented only about 21.5% of BABA’s FY 21 China commerce revenue, the expected rapid CAGR of 44.22% over 3 years from 2019 to 2022 cannot be missed by BABA. Although the market is still relatively small, BABA cannot allow the current leader in this market: PDD to so easily dominate and gobble up the early high growth rates at the ignorance of everyone else. Certainly BABA must compete and fight for its place in this segment and strive for early leadership to prevent PDD from extending its lead.\nPDD profitability metrics & revenue growth forecast. Data source: S&P Capital IQ\nWe could observe from the above chart that PDD is expected to continue growing its revenue rapidly over the next few years, even though they are expected to normalize subsequently. More importantly, PDD is also expected to increasingly improve its EBIT and FCF profitability moving forward. This shows that the Community Marketplace segment is an highly important growth driver that BABA must use its strength to exploit in order to deny PDD’s claim to undisputed leadership so early on in the game.\nChina public cloud spending. Source:China Internet Watch; Canalys\nSize of China public cloud market. Data source: CAICT; Sina.com.cn\nBABA has a 40% share in China’s public cloud market, way ahead of its key competitors. However, it’s important to note that despite this leadership, BABA is still in heavy investment mode to continue growing its market share as China’s public cloud market is expected to grow from 26.48B yuan in 2017 to 230.74B yuan by 2023, which would represent a CAGR of 43.4%, an incredibly stellar growth rate. This is especially clear when we compare China’s growth rate to the worldwide growth rate (see below) as public cloud spending worldwide is expected to grow from $145B in 2017 to $397B by 2022, that would represent a CAGR of 22.3%.\nWorldwide public cloud spending. Data source: Gartner\nWorldwide public cloud market share. Source:CnTechPost; Gartner\nTherefore, I don’t find it surprising that Ali Cloud has continued to extend its lead over Alphabet’s(NASDAQ:GOOGL)(NASDAQ:GOOG)GCP with a market share of 9.5% in 2020. While AMZN remains the clear leader in the market, its market share has been coming down considerably as public cloud spending continues to expand, indicating that there is a huge potential for growth for multiple players to exist. With BABA’s leadership in the rapidly expanding Chinese market, I’m increasingly bullish on the future profit and FCF contribution from this segment to BABA’s performance over time. Although BABA’s cloud segment has not been EBIT profitable yet (FY 21 EBIT margin: -15%, FY 20 EBIT margin: -17.5%), it’s also useful to note that GCP has also not been profitable for Alphabet as well (FY 20 EBIT margin: -42.9%, FY 19 EBIT margin: -52%). Therefore, we need to give BABA some time to scale up its cloud services in APAC and in China where it is expected to have stronger leadership to allow it to grow faster and investors should expect this to be a highly profitable segment over time.\nBABA's Valuations Look Highly Compelling\nNTM TEV / EBIT 3Y range.\nEV / Fwd EBIT and EV / Fwd Rev trend. Data source: S&P Capital IQ\nWhen we consider BABA's TEV / EBIT historical range, where the 3Y mean read 33.54x, BABA’s EV / Fwd EBIT trend certainly imply a hugely undervalued stock as BABA is still expected to grow its revenue and operating profits rapidly. However, as we wanted to obtain greater clarity over how its counterparts are also valued, we thought it would be useful if we value BABA’s EBIT over a set of benchmark companies that is presented below.\nPeers EV / EBIT Valuations. Data source: S&P Capital IQ\nBy using a blend of historical and forward EBIT, we could see that BABA’s EV / EBIT really looks undervalued when compared to the median value of the set of observed values from the benchmark companies. We derived a fair value range for BABA of $294.98 at the midpoint of the range, that represented a potential upside of 40.5% based on the current stock price of $210.\nRisks to Assumptions\nNow, it’s obviously baffling to watch how Mr. Market has decided to discount BABA to such an extent as if the company has lost all its key sources of growth, when in fact there is still so much potential upside coming from its commerce segment, the new marketplace initiatives and its growing Ali Cloud segment, among others. The main realistic reason that we identified for the stock's underperformance would simply be regulatory risk. We think investors should acknowledge that this risk is very real and at times huge Chinese companies have found themselves to be subjected to extra scrutiny (which is nothing new in fact) by the Chinese government. What’s critical here is that the Chinese government seemingly has significant clout over the behavior and actions of their tech behemoths that at times may be largely unpredictable. The market certainly hates unpredictability and therefore they may have significantly discounted BABA as a result of that. If investors are not able to handle uncertainty with regard to potentially unpredictable regulatory actions and their aftermath, then BABA may not be appropriate for you. However, if you believe that this is just a blip in BABA’s long journey, then you would surely find BABA's valuations extremely attractive right now, coupled with a long term mindset.\nWrapping It All Up\nAlibaba has continued to deliver solid results that demonstrated the strong capability of the company to execute well. As the company continues to operate within a market with so many growth drivers that are expected to drive the company’s future growth, investors should find the current valuations highly attractive.","news_type":1},"isVote":1,"tweetType":1,"viewCount":49,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":801986400,"gmtCreate":1627479613800,"gmtModify":1703490756541,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>im super bullish on this , going to 5 dollars EOY","listText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>im super bullish on this , going to 5 dollars EOY","text":"$Sundial Growers Inc.(SNDL)$im super bullish on this , going to 5 dollars EOY","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/801986400","isVote":1,"tweetType":1,"viewCount":458,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":143422540,"gmtCreate":1625811381280,"gmtModify":1703749042395,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>HHappy","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>HHappy","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$HHappy","images":[{"img":"https://static.tigerbbs.com/4d3822f7eae4b1fe1394236b43336d6c","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/143422540","isVote":1,"tweetType":1,"viewCount":215,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":154373689,"gmtCreate":1625484860341,"gmtModify":1703742514403,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>will average down&nbsp;","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>will average down&nbsp;","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$will average down","images":[{"img":"https://static.tigerbbs.com/a05ef1be42ed42c182dfc1a6e1445999","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/154373689","isVote":1,"tweetType":1,"viewCount":92,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":156881367,"gmtCreate":1625210742259,"gmtModify":1703738427398,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"Like and comment to see Tesla to 723 by end of July&nbsp;","listText":"Like and comment to see Tesla to 723 by end of July&nbsp;","text":"Like and comment to see Tesla to 723 by end of July","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/156881367","repostId":"1169411779","repostType":4,"repost":{"id":"1169411779","pubTimestamp":1625204508,"share":"https://www.laohu8.com/m/news/1169411779?lang=&edition=full","pubTime":"2021-07-02 13:41","market":"us","language":"en","title":"Tesla top-of-range car caught fire while owner was driving, lawyer says","url":"https://stock-news.laohu8.com/highlight/detail?id=1169411779","media":"Reuters","summary":"BERKELEY, California, July 1 (Reuters) - A Tesla Inc Model S Plaid electric vehicle burst into flame","content":"<p>BERKELEY, California, July 1 (Reuters) - A Tesla Inc Model S Plaid electric vehicle burst into flames on Tuesday while the owner was driving, just three days after the $129,900, top-of-the-range car was delivered following its June launch, an attorney for the driver told Reuters.</p>\n<p>The driver, identified as an \"executive entrepreneur\", was initially not able to get out of the car because its electronic door system failed, prompting the driver to \"use force to push it open,\" Mark Geragos, of Geragos &amp; Geragos, said on Friday.</p>\n<p>The car continued to move for about 35 feet to 40 feet (11 to 12 meters) before turning into a \"fireball\" in a residential area near the owner's Pennsylvania home.</p>\n<p>\"It was a harrowing and horrifying experience,\" Geragos said.</p>\n<p>\"This is a brand new model... We are doing an investigation. We are calling for the S Plaid to be grounded, not to be on the road until we get to the bottom of this,\" he said.</p>\n<p>Tesla did not have an immediate comment when contacted by Reuters.</p>\n<p>Tesla Chief Executive Elon Musk touted the performance version of its Model S sedan as being \"faster than any Porsche, safer than any Volvo\" at a launch event at the automaker's factory in Fremont, California, last month.</p>\n<p>Earlier in April, he said the new Model S sedan and Model X sport utility vehicle had a new battery pack.</p>\n<p>\"It took quite a bit of development to ensure that the battery of the new S/X is safe,\" Musk said on a conference call, addressing production delays. \"There were more challenges than expected in developing the new version.\"</p>\n<p>Local fire authorities in a now-deleted Facebook post said \"a Tesla was on fire\" and that they cooled \"the batteries down to ensure complete extinguishment\".</p>\n<p>The National Highway Traffic Safety Administration (NHTSA) said it is \"in touch with relevant agencies and the manufacturer to gather information about the incident\".</p>\n<p>\"If data or investigations show a defect or an inherent risk to safety exists, NHTSA will take action as appropriate to protect the public,\" the federal safety agency said.</p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla top-of-range car caught fire while owner was driving, lawyer says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla top-of-range car caught fire while owner was driving, lawyer says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-02 13:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/tesla-top-range-car-caught-053603116.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BERKELEY, California, July 1 (Reuters) - A Tesla Inc Model S Plaid electric vehicle burst into flames on Tuesday while the owner was driving, just three days after the $129,900, top-of-the-range car ...</p>\n\n<a href=\"https://finance.yahoo.com/news/tesla-top-range-car-caught-053603116.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://finance.yahoo.com/news/tesla-top-range-car-caught-053603116.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1169411779","content_text":"BERKELEY, California, July 1 (Reuters) - A Tesla Inc Model S Plaid electric vehicle burst into flames on Tuesday while the owner was driving, just three days after the $129,900, top-of-the-range car was delivered following its June launch, an attorney for the driver told Reuters.\nThe driver, identified as an \"executive entrepreneur\", was initially not able to get out of the car because its electronic door system failed, prompting the driver to \"use force to push it open,\" Mark Geragos, of Geragos & Geragos, said on Friday.\nThe car continued to move for about 35 feet to 40 feet (11 to 12 meters) before turning into a \"fireball\" in a residential area near the owner's Pennsylvania home.\n\"It was a harrowing and horrifying experience,\" Geragos said.\n\"This is a brand new model... We are doing an investigation. We are calling for the S Plaid to be grounded, not to be on the road until we get to the bottom of this,\" he said.\nTesla did not have an immediate comment when contacted by Reuters.\nTesla Chief Executive Elon Musk touted the performance version of its Model S sedan as being \"faster than any Porsche, safer than any Volvo\" at a launch event at the automaker's factory in Fremont, California, last month.\nEarlier in April, he said the new Model S sedan and Model X sport utility vehicle had a new battery pack.\n\"It took quite a bit of development to ensure that the battery of the new S/X is safe,\" Musk said on a conference call, addressing production delays. \"There were more challenges than expected in developing the new version.\"\nLocal fire authorities in a now-deleted Facebook post said \"a Tesla was on fire\" and that they cooled \"the batteries down to ensure complete extinguishment\".\nThe National Highway Traffic Safety Administration (NHTSA) said it is \"in touch with relevant agencies and the manufacturer to gather information about the incident\".\n\"If data or investigations show a defect or an inherent risk to safety exists, NHTSA will take action as appropriate to protect the public,\" the federal safety agency said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":373,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":169843459,"gmtCreate":1623830050371,"gmtModify":1703820730210,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"Interest read, please like and share","listText":"Interest read, please like and share","text":"Interest read, please like and share","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/169843459","repostId":"1182315358","repostType":4,"repost":{"id":"1182315358","pubTimestamp":1623814338,"share":"https://www.laohu8.com/m/news/1182315358?lang=&edition=full","pubTime":"2021-06-16 11:32","market":"us","language":"en","title":"It’s time to be smart like Soros in the ‘blow-off’ stage of the bull market in stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=1182315358","media":"MarketWatch","summary":"If you’re an investor, you need to be flexible, neither a bull nor a bear.\nIt takes brains and brawn","content":"<p>If you’re an investor, you need to be flexible, neither a bull nor a bear.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/724d1ea0bb18bddb367c79abf08c1af9\" tg-width=\"1260\" tg-height=\"841\"><span>It takes brains and brawn to be an investor these days. (Photo by Isaac Lawrence/AFP via Getty Images)</span></p>\n<p>I don’t know when what I call the Blow-Off Top of the Bubble-Blowing Bull Market will end.</p>\n<p>After 12 years being long and strong and having diamond hands without even knowing that term existed, maybe I’m wrong to turn more cautious.</p>\n<p>Maybe the economy will reopen and rejuvenate the country in such a strong manner that corporate earnings in 2022 and 2023 will make today’s prices seem like bargains.</p>\n<p>But I simply don’t think that’s the most likely outcome.</p>\n<p>And if I’m right that we’re in the throes of the Blow-Off Top of the Bubble-Blowing Bull Market, I do not want to be overly long and on the wrong side of the great unwind when it does start.</p>\n<p>I’m not calling for a near-term crash. I am saying that it’s likely going to be hard for the bulls to make as much money this year as they did last year.</p>\n<p>Trading and investing are tough. There’s always someone on the other side of every trade you make. Always think about who that is and why they are willing to take the other side of your transaction. When you buy, why are they selling it to you at that price? When you sell, who is buying it from you and what are their motivations? Remember, I’ve talked before about how&nbsp;good analysis starts with empathy.</p>\n<p><b>If I’m selling, who’s buying — and why?</b></p>\n<p>So let’s answer this question right now. Who is buying stocks and cryptos from me when I’ve trimmed and sold for the past month or so? Sure, there are banks and institutions and hedge funds and family offices investing and trading, just as always. On the other hand, remember two years ago when I got back from a hedge fund investment conference&nbsp;in Abu Dhabi and everybody was desperate for returns:</p>\n<p>Amid low interest rates and other investors’ focus on options, credit and currencies, “the lack of focus on traditional stocks and funds that invest in publicly traded stocks makes me think that there is probably more opportunity in such assets than people realize. I certainly see some very compelling long ideas in Revolutionary companies like WORK and TWTR and TSLA.”</p>\n<p>Since that post, back a year and a half ago, Slack&nbsp;went from $21 to being bought out at $45, Twitter&nbsp;went from $27 to $61, and Tesla&nbsp;went from $81 to $616. And funds that were looking everywhere but in the stock market for big gains are … well, pretty much in the markets now and long a bunch of stocks and even long a few cryptos.</p>\n<p>And now that those stocks and cryptos and most other assets have gone parabolic in the past year — coming on top of the 10-year bull market — the billion-dollar fund managers are joined by&nbsp;23-year-old TikTok influencers&nbsp;doing bitcoin&nbsp;trading astrology.</p>\n<p>Yes, for real, and she’s very popular. She’s even been right about some of bitcoin’s action in the past few months! If you’re selling cryptos and fintech stocks right now, you’re selling to her and her followers. And also to my friend’s son, who just graduated from a tiny, rural school and whose unemployed uncle gave him $500 to “buy some cryptos. And make sure you get some fintech. I don’t know the symbol, but just look it up and you’ll do fine over the long run.”&nbsp;Bearish anecdotes everywhere I look, as I wrote recently.</p>\n<p><b>Mr. Market</b></p>\n<p>The other thing to remember about who’s on the other side of your trade is always to remember that there are smart, cutthroat traders and investors who went to the best schools and have access to more research and real-time data and instant trading access to all kinds of derivatives to layer into their bets. And the only thing they do all day, every day, is figure out how to take your money in mostly legal ways. They’re not playing around. They have no sympathy for you, even if they might empathize with you to better understand your motivations to better take your money.</p>\n<p>Mr. Market is mean. He’s not nice. He can be cruel. He can force liquidations that create other liquidations. He can shut off access to capital. He can take down 200-year-old banks in a day. In one day.</p>\n<p>Sometimes the markets lead the economy and not the other way around. Ironically, when we were young, we were taught that the Great Depression started when the stock market crashed on Black Friday in 1929. But then when we get older, we were taught that it wasn’t actually the crash that created the Great Depression, rather the economy was already crashing and the stock market just didn’t realize it as it continued on its merry way toward a terrible Blow-Off Top of a nine-year Bubble-Blowing Bull Market that culminated with the Dow Jones Industrial Average&nbsp;up 400% from the 1921 lows to the 1929 highs.</p>\n<p><img src=\"https://static.tigerbbs.com/3a6516337aacc614d83584ea90e174f2\" tg-width=\"1260\" tg-height=\"870\"></p>\n<p><b>Learning from Soros</b></p>\n<p>But looking back, it’s clear that both theories are equally right and wrong — the market crashed because the economy wasn’t as good as the market thought it was,<i>and</i>the economy crashed because the markets shut down access to capital for investment and growth.</p>\n<p>It was “reflexive,” to borrow a term from the great hedge fund manager&nbsp;George Soros.</p>\n<p>He wrote, and the concept is important to understand:</p>\n<p>“I continued to consider myself a failed philosopher. All this changed as a result of the financial crisis of 2008. My conceptual framework enabled me both to anticipate the crisis and to deal with it when it finally struck…</p>\n<p>“I can state the core idea in two relatively simple propositions. One is that in situations that have thinking participants, the participants’ view of the world is always partial and distorted. That is the principle of fallibility. The other is that these distorted views can influence the situation to which they relate because false views lead to inappropriate actions. That is the principle of reflexivity…</p>\n<p>“Recognizing reflexivity has been sacrificed to the vain pursuit of certainty in human affairs, most notably in economics, and yet, uncertainty is the key feature of human affairs. Economic theory is built on the concept of equilibrium, and that concept is in direct contradiction with the concept of reflexivity…</p>\n<p>“A positive feedback process is self-reinforcing. It cannot go on forever because eventually the participants’ views would become so far removed from objective reality that the participants would have to recognize them as unrealistic. Nor can the iterative process occur without any change in the actual state of affairs, because it is in the nature of positive feedback that it reinforces whatever tendency prevails in the real world. Instead of equilibrium, we are faced with a dynamic disequilibrium or what may be described as far-from-equilibrium conditions. Usually in far-from-equilibrium situations the divergence between perceptions and reality leads to a climax which sets in motion a positive feedback process in the opposite direction. Such initially self-reinforcing but eventually self-defeating boom-bust processes or bubbles are characteristic of financial markets, but they can also be found in other spheres. There, I call them fertile fallacies—interpretations of reality that are distorted, yet produce results which reinforce the distortion.”</p>\n<p>Stay flexible</p>\n<p>Far-from-equilibrium conditions was what we had in 2010-2013 when we loaded up on Revolutionary stocks and started buying cryptos like bitcoin. Far-from-equilibrium conditions might be what we have in front of us right now when I suggest getting cautious instead.</p>\n<p>We don’t want to be permabulls. (You for sure don’t want to be a permabear!) We have to be flexible. We have to let our analysis and risk/reward scenarios dictate how much risk we’re taking and when. We have to pay attention to the cycles, the self-reinforcing cycles that drive economies and markets and valuations and earnings and societal interactions and bailouts and financial crises and bubbles and busts and, heaven forbid, just simple stagnation.</p>\n<p>It’s as if everybody forgets that markets can bubble and crash and stagnate. They forget that markets can grind for years on end without making new highs, or without even making higher highs. Do you not remember telling your money manager sometime in 2010-2012 that “If I’d just handled the Great Financial Crisis (and/or the Dot-Com Crash) a little better, I’d be in better shape.” I used to hear people say that to me all the time. I haven’t heard anybody say that lately. Everybody’s having fun in this market … at least for now.</p>\n<p>Most traders will tell you that they are “just trading the market that is in front of them.” Well, I don’t know when the bubble will pop, but I do know that I don’t want to be on the wrong side of this market when it does. And I do know that we won’t know the bubble has really popped until the self-reinforcing reflexive feedback loop has made it painful for the vast majority of people who are right now feeling wealthy, feeling secure, feeling like they’ve got this trading and investing thing all figured out.</p>\n<p>We are all fallible. Be careful while it’s fun. Be bold when it’s painful. That’s how I’ve done it for the last 25 years. We were boldly buying these assets when it was painful for others. I’m careful right now because everybody else is having fun.</p>\n<p>I spend a lot of time looking for new ideas and I won’t let my overall market outlook deter me from buying a new name or two. But I want to remain overall cautious and less aggressive than I have been for most of the last decade.</p>\n<p>As a matter of fact,&nbsp;I might have at least a couple Trade Alerts that I’ll be sending out this week, one long and one short idea. Being flexible, see?</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>It’s time to be smart like Soros in the ‘blow-off’ stage of the bull market in stocks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIt’s time to be smart like Soros in the ‘blow-off’ stage of the bull market in stocks\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-16 11:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/its-time-to-be-smart-like-soros-in-the-blow-off-stage-of-the-bull-market-in-stocks-11623788897?siteid=yhoof2><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If you’re an investor, you need to be flexible, neither a bull nor a bear.\nIt takes brains and brawn to be an investor these days. (Photo by Isaac Lawrence/AFP via Getty Images)\nI don’t know when what...</p>\n\n<a href=\"https://www.marketwatch.com/story/its-time-to-be-smart-like-soros-in-the-blow-off-stage-of-the-bull-market-in-stocks-11623788897?siteid=yhoof2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"https://www.marketwatch.com/story/its-time-to-be-smart-like-soros-in-the-blow-off-stage-of-the-bull-market-in-stocks-11623788897?siteid=yhoof2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1182315358","content_text":"If you’re an investor, you need to be flexible, neither a bull nor a bear.\nIt takes brains and brawn to be an investor these days. (Photo by Isaac Lawrence/AFP via Getty Images)\nI don’t know when what I call the Blow-Off Top of the Bubble-Blowing Bull Market will end.\nAfter 12 years being long and strong and having diamond hands without even knowing that term existed, maybe I’m wrong to turn more cautious.\nMaybe the economy will reopen and rejuvenate the country in such a strong manner that corporate earnings in 2022 and 2023 will make today’s prices seem like bargains.\nBut I simply don’t think that’s the most likely outcome.\nAnd if I’m right that we’re in the throes of the Blow-Off Top of the Bubble-Blowing Bull Market, I do not want to be overly long and on the wrong side of the great unwind when it does start.\nI’m not calling for a near-term crash. I am saying that it’s likely going to be hard for the bulls to make as much money this year as they did last year.\nTrading and investing are tough. There’s always someone on the other side of every trade you make. Always think about who that is and why they are willing to take the other side of your transaction. When you buy, why are they selling it to you at that price? When you sell, who is buying it from you and what are their motivations? Remember, I’ve talked before about how good analysis starts with empathy.\nIf I’m selling, who’s buying — and why?\nSo let’s answer this question right now. Who is buying stocks and cryptos from me when I’ve trimmed and sold for the past month or so? Sure, there are banks and institutions and hedge funds and family offices investing and trading, just as always. On the other hand, remember two years ago when I got back from a hedge fund investment conference in Abu Dhabi and everybody was desperate for returns:\nAmid low interest rates and other investors’ focus on options, credit and currencies, “the lack of focus on traditional stocks and funds that invest in publicly traded stocks makes me think that there is probably more opportunity in such assets than people realize. I certainly see some very compelling long ideas in Revolutionary companies like WORK and TWTR and TSLA.”\nSince that post, back a year and a half ago, Slack went from $21 to being bought out at $45, Twitter went from $27 to $61, and Tesla went from $81 to $616. And funds that were looking everywhere but in the stock market for big gains are … well, pretty much in the markets now and long a bunch of stocks and even long a few cryptos.\nAnd now that those stocks and cryptos and most other assets have gone parabolic in the past year — coming on top of the 10-year bull market — the billion-dollar fund managers are joined by 23-year-old TikTok influencers doing bitcoin trading astrology.\nYes, for real, and she’s very popular. She’s even been right about some of bitcoin’s action in the past few months! If you’re selling cryptos and fintech stocks right now, you’re selling to her and her followers. And also to my friend’s son, who just graduated from a tiny, rural school and whose unemployed uncle gave him $500 to “buy some cryptos. And make sure you get some fintech. I don’t know the symbol, but just look it up and you’ll do fine over the long run.” Bearish anecdotes everywhere I look, as I wrote recently.\nMr. Market\nThe other thing to remember about who’s on the other side of your trade is always to remember that there are smart, cutthroat traders and investors who went to the best schools and have access to more research and real-time data and instant trading access to all kinds of derivatives to layer into their bets. And the only thing they do all day, every day, is figure out how to take your money in mostly legal ways. They’re not playing around. They have no sympathy for you, even if they might empathize with you to better understand your motivations to better take your money.\nMr. Market is mean. He’s not nice. He can be cruel. He can force liquidations that create other liquidations. He can shut off access to capital. He can take down 200-year-old banks in a day. In one day.\nSometimes the markets lead the economy and not the other way around. Ironically, when we were young, we were taught that the Great Depression started when the stock market crashed on Black Friday in 1929. But then when we get older, we were taught that it wasn’t actually the crash that created the Great Depression, rather the economy was already crashing and the stock market just didn’t realize it as it continued on its merry way toward a terrible Blow-Off Top of a nine-year Bubble-Blowing Bull Market that culminated with the Dow Jones Industrial Average up 400% from the 1921 lows to the 1929 highs.\n\nLearning from Soros\nBut looking back, it’s clear that both theories are equally right and wrong — the market crashed because the economy wasn’t as good as the market thought it was,andthe economy crashed because the markets shut down access to capital for investment and growth.\nIt was “reflexive,” to borrow a term from the great hedge fund manager George Soros.\nHe wrote, and the concept is important to understand:\n“I continued to consider myself a failed philosopher. All this changed as a result of the financial crisis of 2008. My conceptual framework enabled me both to anticipate the crisis and to deal with it when it finally struck…\n“I can state the core idea in two relatively simple propositions. One is that in situations that have thinking participants, the participants’ view of the world is always partial and distorted. That is the principle of fallibility. The other is that these distorted views can influence the situation to which they relate because false views lead to inappropriate actions. That is the principle of reflexivity…\n“Recognizing reflexivity has been sacrificed to the vain pursuit of certainty in human affairs, most notably in economics, and yet, uncertainty is the key feature of human affairs. Economic theory is built on the concept of equilibrium, and that concept is in direct contradiction with the concept of reflexivity…\n“A positive feedback process is self-reinforcing. It cannot go on forever because eventually the participants’ views would become so far removed from objective reality that the participants would have to recognize them as unrealistic. Nor can the iterative process occur without any change in the actual state of affairs, because it is in the nature of positive feedback that it reinforces whatever tendency prevails in the real world. Instead of equilibrium, we are faced with a dynamic disequilibrium or what may be described as far-from-equilibrium conditions. Usually in far-from-equilibrium situations the divergence between perceptions and reality leads to a climax which sets in motion a positive feedback process in the opposite direction. Such initially self-reinforcing but eventually self-defeating boom-bust processes or bubbles are characteristic of financial markets, but they can also be found in other spheres. There, I call them fertile fallacies—interpretations of reality that are distorted, yet produce results which reinforce the distortion.”\nStay flexible\nFar-from-equilibrium conditions was what we had in 2010-2013 when we loaded up on Revolutionary stocks and started buying cryptos like bitcoin. Far-from-equilibrium conditions might be what we have in front of us right now when I suggest getting cautious instead.\nWe don’t want to be permabulls. (You for sure don’t want to be a permabear!) We have to be flexible. We have to let our analysis and risk/reward scenarios dictate how much risk we’re taking and when. We have to pay attention to the cycles, the self-reinforcing cycles that drive economies and markets and valuations and earnings and societal interactions and bailouts and financial crises and bubbles and busts and, heaven forbid, just simple stagnation.\nIt’s as if everybody forgets that markets can bubble and crash and stagnate. They forget that markets can grind for years on end without making new highs, or without even making higher highs. Do you not remember telling your money manager sometime in 2010-2012 that “If I’d just handled the Great Financial Crisis (and/or the Dot-Com Crash) a little better, I’d be in better shape.” I used to hear people say that to me all the time. I haven’t heard anybody say that lately. Everybody’s having fun in this market … at least for now.\nMost traders will tell you that they are “just trading the market that is in front of them.” Well, I don’t know when the bubble will pop, but I do know that I don’t want to be on the wrong side of this market when it does. And I do know that we won’t know the bubble has really popped until the self-reinforcing reflexive feedback loop has made it painful for the vast majority of people who are right now feeling wealthy, feeling secure, feeling like they’ve got this trading and investing thing all figured out.\nWe are all fallible. Be careful while it’s fun. Be bold when it’s painful. That’s how I’ve done it for the last 25 years. We were boldly buying these assets when it was painful for others. I’m careful right now because everybody else is having fun.\nI spend a lot of time looking for new ideas and I won’t let my overall market outlook deter me from buying a new name or two. But I want to remain overall cautious and less aggressive than I have been for most of the last decade.\nAs a matter of fact, I might have at least a couple Trade Alerts that I’ll be sending out this week, one long and one short idea. Being flexible, see?","news_type":1},"isVote":1,"tweetType":1,"viewCount":121,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9095115453,"gmtCreate":1644850664500,"gmtModify":1676533967854,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/CTIC\">$CTI BioPharma(CTIC)$</a>Fda soon diamond hands","listText":"<a href=\"https://ttm.financial/S/CTIC\">$CTI BioPharma(CTIC)$</a>Fda soon diamond hands","text":"$CTI BioPharma(CTIC)$Fda soon diamond hands","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095115453","isVote":1,"tweetType":1,"viewCount":355,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":146842170,"gmtCreate":1626070166390,"gmtModify":1703752748766,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/WKHS\">$Workhorse(WKHS)$</a>it should hover around 12-13 dollars by end of this week","listText":"<a href=\"https://laohu8.com/S/WKHS\">$Workhorse(WKHS)$</a>it should hover around 12-13 dollars by end of this week","text":"$Workhorse(WKHS)$it should hover around 12-13 dollars by end of this week","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/146842170","isVote":1,"tweetType":1,"viewCount":254,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":187306614,"gmtCreate":1623738259338,"gmtModify":1704210037845,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"Nicely done","listText":"Nicely done","text":"Nicely done","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/187306614","repostId":"1175897310","repostType":4,"repost":{"id":"1175897310","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1623725513,"share":"https://www.laohu8.com/m/news/1175897310?lang=&edition=full","pubTime":"2021-06-15 10:51","market":"us","language":"en","title":"IPO Preview: WalkMe, Atai Life Sciences Highlight Week Of Many Offerings","url":"https://stock-news.laohu8.com/highlight/detail?id=1175897310","media":"Benzinga","summary":"This week’s IPO lineup could feature a double digit number of companies hitting the public. Here is ","content":"<p>This week’s IPO lineup could feature a double digit number of companies hitting the public. Here is a look at some of the largest and most high profile companies going public this week.</p>\n<p><b>AMTD Digital:</b>Asian digital solutions platform&nbsp;<b>AMTD Digital</b>(NYSE:HKD)&nbsp;offers&nbsp;risk solutions and digital insurance technology for partners. The company had revenue of $21.6 million in fiscal 2020 and $18.8 million through the first nine months of the current fiscal year. The company plans to sell 16 million ADSs at a price point of $6.80 to $8.20.</p>\n<p><b>Molecular Partners:</b>Clinical stage biotechnology company&nbsp;<b>Molecular Partners</b>(NASDAQ:MOLN) isfocusedon using its pioneering DARPin product in categories including infectious diseases, oncology and ophthalmology. The company partnered with&nbsp;<b>Novartis</b>(NYSE:NVS) in 2020,<b>Amgen Inc</b>(NASDAQ:AMGN) in 2018 and&nbsp;<b>AbbVie Inc</b>(NYSE:ABBV) in 2011. Novartis owns 6% of the company. Molecular Partners plans to sell 3 million ADS.</p>\n<p><b>WalkMe:</b>With a mission to change the way humans interact with technology,<b>WalkMe</b>(NASDAQ:WKME)offerssolutions for organizations. The company has many well-known companies as customers including Nestle and Veolia, two large European companies listed as case studies in the filing.</p>\n<p>WalkMe had revenue of $148 million in 2020 and revenue of $42.7 million in the first quarter of 2021. The company’s revenue was up 34% year-over-year in the last twelve months. The company has 368 customers that represent $100,000 or more in annual revenue and 22 customers that represent $1 million or more in annual revenue. WalkMe plans on selling 9.25 million shares at a price point of $29 to $32.</p>\n<p><b>Convey Holding:</b>Health care company&nbsp;<b>Convey Holding</b>(NYSE:CNVY)partnerswith eight of the 10 largest Medicare Advantage companies in the U.S. The company had 2.5 million Medicare Advantage and 1.6 million Prescription Drug Plan members in 2020. Revenue in 2020 for the company was $282.9 million. First-quarter 2021 revenue was $82.6 million for the company. Convey Holding plans to sell 13.3 million shares at a price point of $14 to $16.</p>\n<p><b>Angel Oak Mortgage:</b>Real estate finance company&nbsp;<b>Angel Oak Mortgage</b>(NYSE: AOMR)&nbsp;acquiresand invests in first&nbsp;lien non-QM Loans and other mortgage assets in the U.S. The company had assets of $534.9 million at the end of the first quarter of 2021. The company has elected to be taxed as a REIT. Angel Oak Mortgage is seeking to sell 8.1 million shares at a price point of $20 to $21.</p>\n<p><b>Lyell Immunopharma:</b>Seeking to disrupt the T-cell reprogramming market,<b>Lyell ImmunoPharma</b>(NASDAQ:LYEL)intendsto have four INDs submitted by the end of 2022. The company partnered with<b>GlaxoSmithKline</b>(NYSE:GSK) in 2019 in a deal good for up to $400 million in additional milestones after a $45-million upfront payment.</p>\n<p>GlaxoSmithKline owns 14% of Lyell and&nbsp;<b>Bristol-MyersSquibb</b>(NYSE:BMY) owned Celgene owns 5% of the company. Lyell is planning to sell 25 million shares at a price point of $16 to $18.</p>\n<p><b>Verve Therapeutics:</b>Genetic medicine company<b>Verve Therapeutics</b>(NASDAQ: VERV) isfocusedon cardiovascular disease. The company plans to sell 11.8 million shares at a price point of $16 to $18.</p>\n<p><b>Atai Life Sciences:</b>Backedby&nbsp;<b>Palantir Technologies</b>(NYSE:PLTR) and&nbsp;<b>Paypal Holdings</b>(NASDAQ:PYPL) founder Peter Thiel,<b>Atai Life Sciences</b>(NASDAQ:ATAI) could be one of the high profile IPOs of the week.</p>\n<p>The company isdevelopingtreatment options for mental health disorders. The company has 10 programs in its pipeline and six enabling technologies. The company is planning on selling 14.3 million shares at a price point of $13 to $15.</p>\n<p><b>AiHui Shou International:</b>Pre-owned consumer electronics reseller&nbsp;<b>AiHuiShou International</b>(NYSE: RERE)seeksto give a second life to all idle goods.</p>\n<p>The company’s three business lines — AHS Recycle, PJUT Marketplace and PaiPai Marketplace — help the company as the market leader in China with a market share of 6.6%. The company had revenue of $741.5 million in 2020 and $231.1 million in the first quarter of 2021, up 119% year-over-year.<b>JD.com</b>(NASDAQ:JD) will own 32.3% of the company after the IPO. The company plans on selling 16.2 million ADSs at a price point of $13 to $15.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IPO Preview: WalkMe, Atai Life Sciences Highlight Week Of Many Offerings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIPO Preview: WalkMe, Atai Life Sciences Highlight Week Of Many Offerings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-06-15 10:51</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>This week’s IPO lineup could feature a double digit number of companies hitting the public. Here is a look at some of the largest and most high profile companies going public this week.</p>\n<p><b>AMTD Digital:</b>Asian digital solutions platform&nbsp;<b>AMTD Digital</b>(NYSE:HKD)&nbsp;offers&nbsp;risk solutions and digital insurance technology for partners. The company had revenue of $21.6 million in fiscal 2020 and $18.8 million through the first nine months of the current fiscal year. The company plans to sell 16 million ADSs at a price point of $6.80 to $8.20.</p>\n<p><b>Molecular Partners:</b>Clinical stage biotechnology company&nbsp;<b>Molecular Partners</b>(NASDAQ:MOLN) isfocusedon using its pioneering DARPin product in categories including infectious diseases, oncology and ophthalmology. The company partnered with&nbsp;<b>Novartis</b>(NYSE:NVS) in 2020,<b>Amgen Inc</b>(NASDAQ:AMGN) in 2018 and&nbsp;<b>AbbVie Inc</b>(NYSE:ABBV) in 2011. Novartis owns 6% of the company. Molecular Partners plans to sell 3 million ADS.</p>\n<p><b>WalkMe:</b>With a mission to change the way humans interact with technology,<b>WalkMe</b>(NASDAQ:WKME)offerssolutions for organizations. The company has many well-known companies as customers including Nestle and Veolia, two large European companies listed as case studies in the filing.</p>\n<p>WalkMe had revenue of $148 million in 2020 and revenue of $42.7 million in the first quarter of 2021. The company’s revenue was up 34% year-over-year in the last twelve months. The company has 368 customers that represent $100,000 or more in annual revenue and 22 customers that represent $1 million or more in annual revenue. WalkMe plans on selling 9.25 million shares at a price point of $29 to $32.</p>\n<p><b>Convey Holding:</b>Health care company&nbsp;<b>Convey Holding</b>(NYSE:CNVY)partnerswith eight of the 10 largest Medicare Advantage companies in the U.S. The company had 2.5 million Medicare Advantage and 1.6 million Prescription Drug Plan members in 2020. Revenue in 2020 for the company was $282.9 million. First-quarter 2021 revenue was $82.6 million for the company. Convey Holding plans to sell 13.3 million shares at a price point of $14 to $16.</p>\n<p><b>Angel Oak Mortgage:</b>Real estate finance company&nbsp;<b>Angel Oak Mortgage</b>(NYSE: AOMR)&nbsp;acquiresand invests in first&nbsp;lien non-QM Loans and other mortgage assets in the U.S. The company had assets of $534.9 million at the end of the first quarter of 2021. The company has elected to be taxed as a REIT. Angel Oak Mortgage is seeking to sell 8.1 million shares at a price point of $20 to $21.</p>\n<p><b>Lyell Immunopharma:</b>Seeking to disrupt the T-cell reprogramming market,<b>Lyell ImmunoPharma</b>(NASDAQ:LYEL)intendsto have four INDs submitted by the end of 2022. The company partnered with<b>GlaxoSmithKline</b>(NYSE:GSK) in 2019 in a deal good for up to $400 million in additional milestones after a $45-million upfront payment.</p>\n<p>GlaxoSmithKline owns 14% of Lyell and&nbsp;<b>Bristol-MyersSquibb</b>(NYSE:BMY) owned Celgene owns 5% of the company. Lyell is planning to sell 25 million shares at a price point of $16 to $18.</p>\n<p><b>Verve Therapeutics:</b>Genetic medicine company<b>Verve Therapeutics</b>(NASDAQ: VERV) isfocusedon cardiovascular disease. The company plans to sell 11.8 million shares at a price point of $16 to $18.</p>\n<p><b>Atai Life Sciences:</b>Backedby&nbsp;<b>Palantir Technologies</b>(NYSE:PLTR) and&nbsp;<b>Paypal Holdings</b>(NASDAQ:PYPL) founder Peter Thiel,<b>Atai Life Sciences</b>(NASDAQ:ATAI) could be one of the high profile IPOs of the week.</p>\n<p>The company isdevelopingtreatment options for mental health disorders. The company has 10 programs in its pipeline and six enabling technologies. The company is planning on selling 14.3 million shares at a price point of $13 to $15.</p>\n<p><b>AiHui Shou International:</b>Pre-owned consumer electronics reseller&nbsp;<b>AiHuiShou International</b>(NYSE: RERE)seeksto give a second life to all idle goods.</p>\n<p>The company’s three business lines — AHS Recycle, PJUT Marketplace and PaiPai Marketplace — help the company as the market leader in China with a market share of 6.6%. The company had revenue of $741.5 million in 2020 and $231.1 million in the first quarter of 2021, up 119% year-over-year.<b>JD.com</b>(NASDAQ:JD) will own 32.3% of the company after the IPO. The company plans on selling 16.2 million ADSs at a price point of $13 to $15.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVS":"诺华","CNVY":"Convey Holding Parent, Inc.","AOMR":"ANGEL OAK MORTGAGE REIT INC","LYEL":"Lyell Immunopharma, Inc.","HKD":"尚乘数科","RERE":"万物新生","MOLN":"Molecular Partners AG","WKME":"WalkMe Ltd.","ATAI":"ATAI Life Sciences B.V.*"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1175897310","content_text":"This week’s IPO lineup could feature a double digit number of companies hitting the public. Here is a look at some of the largest and most high profile companies going public this week.\nAMTD Digital:Asian digital solutions platform AMTD Digital(NYSE:HKD) offers risk solutions and digital insurance technology for partners. The company had revenue of $21.6 million in fiscal 2020 and $18.8 million through the first nine months of the current fiscal year. The company plans to sell 16 million ADSs at a price point of $6.80 to $8.20.\nMolecular Partners:Clinical stage biotechnology company Molecular Partners(NASDAQ:MOLN) isfocusedon using its pioneering DARPin product in categories including infectious diseases, oncology and ophthalmology. The company partnered with Novartis(NYSE:NVS) in 2020,Amgen Inc(NASDAQ:AMGN) in 2018 and AbbVie Inc(NYSE:ABBV) in 2011. Novartis owns 6% of the company. Molecular Partners plans to sell 3 million ADS.\nWalkMe:With a mission to change the way humans interact with technology,WalkMe(NASDAQ:WKME)offerssolutions for organizations. The company has many well-known companies as customers including Nestle and Veolia, two large European companies listed as case studies in the filing.\nWalkMe had revenue of $148 million in 2020 and revenue of $42.7 million in the first quarter of 2021. The company’s revenue was up 34% year-over-year in the last twelve months. The company has 368 customers that represent $100,000 or more in annual revenue and 22 customers that represent $1 million or more in annual revenue. WalkMe plans on selling 9.25 million shares at a price point of $29 to $32.\nConvey Holding:Health care company Convey Holding(NYSE:CNVY)partnerswith eight of the 10 largest Medicare Advantage companies in the U.S. The company had 2.5 million Medicare Advantage and 1.6 million Prescription Drug Plan members in 2020. Revenue in 2020 for the company was $282.9 million. First-quarter 2021 revenue was $82.6 million for the company. Convey Holding plans to sell 13.3 million shares at a price point of $14 to $16.\nAngel Oak Mortgage:Real estate finance company Angel Oak Mortgage(NYSE: AOMR) acquiresand invests in first lien non-QM Loans and other mortgage assets in the U.S. The company had assets of $534.9 million at the end of the first quarter of 2021. The company has elected to be taxed as a REIT. Angel Oak Mortgage is seeking to sell 8.1 million shares at a price point of $20 to $21.\nLyell Immunopharma:Seeking to disrupt the T-cell reprogramming market,Lyell ImmunoPharma(NASDAQ:LYEL)intendsto have four INDs submitted by the end of 2022. The company partnered withGlaxoSmithKline(NYSE:GSK) in 2019 in a deal good for up to $400 million in additional milestones after a $45-million upfront payment.\nGlaxoSmithKline owns 14% of Lyell and Bristol-MyersSquibb(NYSE:BMY) owned Celgene owns 5% of the company. Lyell is planning to sell 25 million shares at a price point of $16 to $18.\nVerve Therapeutics:Genetic medicine companyVerve Therapeutics(NASDAQ: VERV) isfocusedon cardiovascular disease. The company plans to sell 11.8 million shares at a price point of $16 to $18.\nAtai Life Sciences:Backedby Palantir Technologies(NYSE:PLTR) and Paypal Holdings(NASDAQ:PYPL) founder Peter Thiel,Atai Life Sciences(NASDAQ:ATAI) could be one of the high profile IPOs of the week.\nThe company isdevelopingtreatment options for mental health disorders. The company has 10 programs in its pipeline and six enabling technologies. The company is planning on selling 14.3 million shares at a price point of $13 to $15.\nAiHui Shou International:Pre-owned consumer electronics reseller AiHuiShou International(NYSE: RERE)seeksto give a second life to all idle goods.\nThe company’s three business lines — AHS Recycle, PJUT Marketplace and PaiPai Marketplace — help the company as the market leader in China with a market share of 6.6%. The company had revenue of $741.5 million in 2020 and $231.1 million in the first quarter of 2021, up 119% year-over-year.JD.com(NASDAQ:JD) will own 32.3% of the company after the IPO. The company plans on selling 16.2 million ADSs at a price point of $13 to $15.","news_type":1},"isVote":1,"tweetType":1,"viewCount":5,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":197142683,"gmtCreate":1621435866442,"gmtModify":1704357656955,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"You are not alone","listText":"You are not alone","text":"You are not alone","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/197142683","repostId":"192857082","repostType":1,"repost":{"id":192857082,"gmtCreate":1621182800446,"gmtModify":1704353691016,"author":{"id":"3572963681970248","authorId":"3572963681970248","name":"IreneCQ","avatar":"https://community-static.tradeup.com/news/4f6169df16c4194b906e5826253aa1b1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ACTC\">$ArcLight Clean Transition Corp(ACTC)$</a>Nooo","listText":"<a href=\"https://laohu8.com/S/ACTC\">$ArcLight Clean Transition Corp(ACTC)$</a>Nooo","text":"$ArcLight Clean Transition Corp(ACTC)$Nooo","images":[{"img":"https://static.tigerbbs.com/51481231294c20425aa4e5bdadd4840c","width":"1242","height":"1767"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/192857082","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":261,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":881388490,"gmtCreate":1631293095210,"gmtModify":1676530523202,"author":{"id":"3582700103615177","authorId":"3582700103615177","name":"AaronHeng","avatar":"https://static.tigerbbs.com/994c4b2af7dab72f2e4d223f3e9d3f2e","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"Nice to spread fud , I don't think value investment is the in thing now , memestock ftw","listText":"Nice to spread fud , I don't think value investment is the in thing now , memestock ftw","text":"Nice to spread fud , I don't think value investment is the in thing now , memestock ftw","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/881388490","repostId":"2165353911","repostType":2,"repost":{"id":"2165353911","pubTimestamp":1631015340,"share":"https://www.laohu8.com/m/news/2165353911?lang=&edition=full","pubTime":"2021-09-07 19:49","market":"us","language":"en","title":"5 Ultra-Popular Stocks to Avoid Like the Plague in September","url":"https://stock-news.laohu8.com/highlight/detail?id=2165353911","media":"Motley Fool","summary":"Popularity doesn't necessarily translate to profitability on Wall Street.","content":"<blockquote>\n <b>Popularity doesn't necessarily translate to profitability on Wall Street.</b>\n</blockquote>\n<p><b>Key Points</b></p>\n<ul>\n <li>Though the S&amp;P 500 is soaring, the valuations of these stocks make little sense.</li>\n</ul>\n<p>For more than 17 months, investors have enjoyed a historic bounce-back rally in the stock market. Following the quickest decline of at least 30% in the history of the broad-based <b>S&amp;P 500</b>, the index has since rallied more than 100% off of its low.</p>\n<p>But just because the market is in rally mode, it doesn't mean every stock deserves its current valuation. The following five ultra-popular stocks are on the radar for all the wrong reasons, and they should be avoided like the plague in September.</p>\n<p><img src=\"https://static.tigerbbs.com/8b2e6f5c48ac79126a7c69a95b9659ed\" tg-width=\"700\" tg-height=\"484\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<p><b>AMC Entertainment</b></p>\n<p>As I stated last month, movie theater chain <b>AMC Entertainment </b>(NYSE:AMC) will be the top stock to avoid until its share price accurately reflects the ghastly performance of its underlying business and its ugly balance sheet.</p>\n<p>There pretty much isn't a fundamental factor working in AMC's favor at the moment. Box office ticket sales have consistently been 30% or more below what they were in 2019, and ticket sales had been declining at a fairly steady clip since 2002. CEO Adam Aron has touted AMC's ability to pick up market share during the pandemic, but he overlooks that the actual movie theater pie has been shrinking for two decades.</p>\n<p>More specific to the company, it burned through close to $577 million in cash in just the first six months of 2021. It's also sitting on $5.5 billion in corporate debt, along with $420 million in deferred rent, all of which will need to be repaid in cash. AMC's cash balance at the end of June was a hair over $1.8 billion, or roughly $2 billion if you include the company's untapped revolving credit line. No matter how you finagle the numbers, AMC has virtually no chance of repaying its obligations, and its bondholders know it, which is why more than $1 billion in combined 2026/2027 maturity bonds are valued at 60% to 65% of face value.</p>\n<p>The icing on the cake here is that a multitude of theses surrounding an AMC short squeeze aren't supported by fact. Put plainly, a company that was never worth more than $3.8 billion when it was profitable and could pay its debt obligations shouldn't be worth $22 billion when it's hemorrhaging cash and can't pay its obligations.</p>\n<p><img src=\"https://static.tigerbbs.com/0c88358ead583aa5db4844d5902510f8\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<p><b>Zomedica</b></p>\n<p>Generally speaking, penny stocks (companies with a share price below $5) are penny stocks for a reason. In other words, companies sport a low share price because they're not performing well from an operating standpoint. That's the case with veterinary medicine and diagnostics company <b>Zomedica </b>(NYSEMKT:ZOM).</p>\n<p>On the surface, there's a lot to like. Pet expenditures in the U.S. haven't declined on a year-over-year basis in more than a quarter of a century, and an estimated $32.3 billion will be spent this year in the U.S. on veterinary care and product sales, according to the American Pet Products Association.&nbsp; To boot, Zomedica launched its first-ever commercial product in March. Truforma, as it's known, is a point-of-care diagnostics system for cats and dogs.</p>\n<p>The problem is that Truforma just isn't selling. While the company blamed its commercial launch challenges on the sale of its distribution partner, it's still an eye-opener that the company has managed only $29,817 in total sales since its March launch. Although sales will undoubtedly grow as management works out the kinks, I have to wonder what investor wants to pay a multiple of almost 40 times estimated sales for 2022.</p>\n<p>With no clear pathway to profitability anytime soon, and management diluting the daylights out of its shareholders to raise cash (there are nearly 980 million outstanding shares), Zomedica is an easy avoid in September.</p>\n<p><img src=\"https://static.tigerbbs.com/ebe3f403b1b970d0e231952ef9c1d01c\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<p><b>Robinhood Markets</b></p>\n<p>Another ultra-popular stock that should be draped in yellow caution tape for September is online investing app <b>Robinhood Markets</b> (NASDAQ:HOOD).</p>\n<p>On <a href=\"https://laohu8.com/S/AONE.U\">one</a> hand, Robinhood has seen its user growth blossom since the pandemic began. In the 18-month period between Dec. 31, 2019 and June 30, 2021, the company's funded accounts have grown from about 10 million to 22.5 million. It also now has more than $100 billion in assets under custody. As retail investors have flocked to Robinhood, revenue has soared.</p>\n<p>But this doesn't tell the full story. Even though its customer count has risen, Robinhood has rubbed retail investors and U.S. regulators the wrong way. The company had to pare back trading activity earlier this year on heavily shorted meme stocks (companies lauded for their social media buzz, rather than their operating performance) because it lacked the capital to support heightened trading activity. It's drawn ire from regulators over its sale of order flow to hedge funds, as well.</p>\n<p>Robinhood's operating model also looks as if it could be easily disrupted. Even though it's best known for attracting retail investors, and the company can generate revenue from certain trading activities, such as options, it generates a good chunk of its revenue from selling order to flow to a small handful of hedge funds and institutional investors. If any of these clients were to stop paying for order flow, or if new regulations altered how order flow was sold, Robinhood could be in big trouble.</p>\n<p><img src=\"https://static.tigerbbs.com/df6ef536d43baa33372dde88018439ea\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<p><b>Aurora Cannabis</b></p>\n<p>Let's face the facts: A majority of Canadian marijuana stocks have no business in investors' portfolios. But time and again <b>Aurora Cannabis</b> (NASDAQ:ACB) has demonstrated that it's one of the worst of the bunch and should be avoided at all costs.</p>\n<p>When Canada legalized recreational weed in October 2018, Aurora looked to be set for success. It eventually held 15 production facilities (many in various stages of development), and anticipated generating a lot of sales via overseas exports. But in the nearly three years since our northerly neighbor waved the green flag on adult-use cannabis, Aurora's international revenue is still minimal, and it's shuttered, sold, or halted construction on more than half of the facilities it once held.</p>\n<p>I can only imagine that one of the more consistently irritating aspects of being an Aurora Cannabis shareholder is the constant dilution. With the former and current management team using the company's shares as collateral to make acquisitions and/or keep the lights on, the company's share count has ballooned from a reverse-split-adjusted 1.3 million to around 198 million in under seven years. With the company racking up 232.3 million Canadian dollars ($185.4 million) in operating losses through the first nine months of fiscal 2021, it's unlikely this share-based dilution is anywhere near finished.</p>\n<p>Want another reason to avoid Aurora? Over the past two years, the company has written down approximately half the value of its total assets (about CA$2.8 billion). It's simply one of the worst stocks to play the cannabis boom.</p>\n<p><img src=\"https://static.tigerbbs.com/07841e6a8173146a0fbfddf95a0f1ccb\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<p><b>GameStop</b></p>\n<p>Since this list of companies to avoid began with a meme stock (AMC), perhaps it's only fitting that it end with another one: <b>GameStop</b> (NYSE:GME).</p>\n<p>Whereas AMC is a fundamental nightmare in every respect, video game and accessories retailer GameStop does at least have a few things working in its favor. For instance, the company was able to raise enough cash to take care of its debt and undertake what'll likely be a multiyear turnaround focused on digital gaming. Additionally, whereas movie theater industry sales are shrinking, digital gaming is expanding, which offers growth opportunities for GameStop.</p>\n<p>The issue, though, is that GameStop is going to take years to turn things around. This is a company that's been built on a brick-and-mortar operating model for more than two decades. As gaming shifts online, GameStop will be forced to close stores at a steady pace to reduce its operating expenses and essentially backpedal its way into the profit column. Though GameStop can be profitable again on a recurring basis, its $15 billion market cap isn't accurately reflective of the challenges that lie ahead.</p>\n<p>If given the choice, I'd choose GameStop over AMC over the long run 1,000 times out of 1,000. But I believe there are much smarter places for investors to put their money right now than a gaming retailer whose sales will likely be stagnant for years.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Ultra-Popular Stocks to Avoid Like the Plague in September</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Ultra-Popular Stocks to Avoid Like the Plague in September\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-07 19:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/07/5-ultra-popular-stocks-avoid-like-plague-september/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Popularity doesn't necessarily translate to profitability on Wall Street.\n\nKey Points\n\nThough the S&P 500 is soaring, the valuations of these stocks make little sense.\n\nFor more than 17 months, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/07/5-ultra-popular-stocks-avoid-like-plague-september/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HOOD":"Robinhood","GME":"游戏驿站","AMC":"AMC院线","ZOM":"Zomedica Pharmaceuticals Corp.","ACB":"奥罗拉大麻公司"},"source_url":"https://www.fool.com/investing/2021/09/07/5-ultra-popular-stocks-avoid-like-plague-september/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2165353911","content_text":"Popularity doesn't necessarily translate to profitability on Wall Street.\n\nKey Points\n\nThough the S&P 500 is soaring, the valuations of these stocks make little sense.\n\nFor more than 17 months, investors have enjoyed a historic bounce-back rally in the stock market. Following the quickest decline of at least 30% in the history of the broad-based S&P 500, the index has since rallied more than 100% off of its low.\nBut just because the market is in rally mode, it doesn't mean every stock deserves its current valuation. The following five ultra-popular stocks are on the radar for all the wrong reasons, and they should be avoided like the plague in September.\n\nImage source: Getty Images.\nAMC Entertainment\nAs I stated last month, movie theater chain AMC Entertainment (NYSE:AMC) will be the top stock to avoid until its share price accurately reflects the ghastly performance of its underlying business and its ugly balance sheet.\nThere pretty much isn't a fundamental factor working in AMC's favor at the moment. Box office ticket sales have consistently been 30% or more below what they were in 2019, and ticket sales had been declining at a fairly steady clip since 2002. CEO Adam Aron has touted AMC's ability to pick up market share during the pandemic, but he overlooks that the actual movie theater pie has been shrinking for two decades.\nMore specific to the company, it burned through close to $577 million in cash in just the first six months of 2021. It's also sitting on $5.5 billion in corporate debt, along with $420 million in deferred rent, all of which will need to be repaid in cash. AMC's cash balance at the end of June was a hair over $1.8 billion, or roughly $2 billion if you include the company's untapped revolving credit line. No matter how you finagle the numbers, AMC has virtually no chance of repaying its obligations, and its bondholders know it, which is why more than $1 billion in combined 2026/2027 maturity bonds are valued at 60% to 65% of face value.\nThe icing on the cake here is that a multitude of theses surrounding an AMC short squeeze aren't supported by fact. Put plainly, a company that was never worth more than $3.8 billion when it was profitable and could pay its debt obligations shouldn't be worth $22 billion when it's hemorrhaging cash and can't pay its obligations.\n\nImage source: Getty Images.\nZomedica\nGenerally speaking, penny stocks (companies with a share price below $5) are penny stocks for a reason. In other words, companies sport a low share price because they're not performing well from an operating standpoint. That's the case with veterinary medicine and diagnostics company Zomedica (NYSEMKT:ZOM).\nOn the surface, there's a lot to like. Pet expenditures in the U.S. haven't declined on a year-over-year basis in more than a quarter of a century, and an estimated $32.3 billion will be spent this year in the U.S. on veterinary care and product sales, according to the American Pet Products Association.  To boot, Zomedica launched its first-ever commercial product in March. Truforma, as it's known, is a point-of-care diagnostics system for cats and dogs.\nThe problem is that Truforma just isn't selling. While the company blamed its commercial launch challenges on the sale of its distribution partner, it's still an eye-opener that the company has managed only $29,817 in total sales since its March launch. Although sales will undoubtedly grow as management works out the kinks, I have to wonder what investor wants to pay a multiple of almost 40 times estimated sales for 2022.\nWith no clear pathway to profitability anytime soon, and management diluting the daylights out of its shareholders to raise cash (there are nearly 980 million outstanding shares), Zomedica is an easy avoid in September.\n\nImage source: Getty Images.\nRobinhood Markets\nAnother ultra-popular stock that should be draped in yellow caution tape for September is online investing app Robinhood Markets (NASDAQ:HOOD).\nOn one hand, Robinhood has seen its user growth blossom since the pandemic began. In the 18-month period between Dec. 31, 2019 and June 30, 2021, the company's funded accounts have grown from about 10 million to 22.5 million. It also now has more than $100 billion in assets under custody. As retail investors have flocked to Robinhood, revenue has soared.\nBut this doesn't tell the full story. Even though its customer count has risen, Robinhood has rubbed retail investors and U.S. regulators the wrong way. The company had to pare back trading activity earlier this year on heavily shorted meme stocks (companies lauded for their social media buzz, rather than their operating performance) because it lacked the capital to support heightened trading activity. It's drawn ire from regulators over its sale of order flow to hedge funds, as well.\nRobinhood's operating model also looks as if it could be easily disrupted. Even though it's best known for attracting retail investors, and the company can generate revenue from certain trading activities, such as options, it generates a good chunk of its revenue from selling order to flow to a small handful of hedge funds and institutional investors. If any of these clients were to stop paying for order flow, or if new regulations altered how order flow was sold, Robinhood could be in big trouble.\n\nImage source: Getty Images.\nAurora Cannabis\nLet's face the facts: A majority of Canadian marijuana stocks have no business in investors' portfolios. But time and again Aurora Cannabis (NASDAQ:ACB) has demonstrated that it's one of the worst of the bunch and should be avoided at all costs.\nWhen Canada legalized recreational weed in October 2018, Aurora looked to be set for success. It eventually held 15 production facilities (many in various stages of development), and anticipated generating a lot of sales via overseas exports. But in the nearly three years since our northerly neighbor waved the green flag on adult-use cannabis, Aurora's international revenue is still minimal, and it's shuttered, sold, or halted construction on more than half of the facilities it once held.\nI can only imagine that one of the more consistently irritating aspects of being an Aurora Cannabis shareholder is the constant dilution. With the former and current management team using the company's shares as collateral to make acquisitions and/or keep the lights on, the company's share count has ballooned from a reverse-split-adjusted 1.3 million to around 198 million in under seven years. With the company racking up 232.3 million Canadian dollars ($185.4 million) in operating losses through the first nine months of fiscal 2021, it's unlikely this share-based dilution is anywhere near finished.\nWant another reason to avoid Aurora? Over the past two years, the company has written down approximately half the value of its total assets (about CA$2.8 billion). It's simply one of the worst stocks to play the cannabis boom.\n\nImage source: Getty Images.\nGameStop\nSince this list of companies to avoid began with a meme stock (AMC), perhaps it's only fitting that it end with another one: GameStop (NYSE:GME).\nWhereas AMC is a fundamental nightmare in every respect, video game and accessories retailer GameStop does at least have a few things working in its favor. For instance, the company was able to raise enough cash to take care of its debt and undertake what'll likely be a multiyear turnaround focused on digital gaming. Additionally, whereas movie theater industry sales are shrinking, digital gaming is expanding, which offers growth opportunities for GameStop.\nThe issue, though, is that GameStop is going to take years to turn things around. This is a company that's been built on a brick-and-mortar operating model for more than two decades. As gaming shifts online, GameStop will be forced to close stores at a steady pace to reduce its operating expenses and essentially backpedal its way into the profit column. Though GameStop can be profitable again on a recurring basis, its $15 billion market cap isn't accurately reflective of the challenges that lie ahead.\nIf given the choice, I'd choose GameStop over AMC over the long run 1,000 times out of 1,000. But I believe there are much smarter places for investors to put their money right now than a gaming retailer whose sales will likely be stagnant for years.","news_type":1},"isVote":1,"tweetType":1,"viewCount":321,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}